The Global Androgens and Anabolic Steroids Market size is valued at USD 52.63 Billion in 2022 and is projected to be USD 124.18 Billion by 2030, growing at a CAGR of 10.4% from 2023 to 2030, as per a recent report published by Cognitive Market Research. Androgens and anabolic steroids market in North America (especially in the U.S.) held the largest market share. For instance, Testosterone Gel 1.62% CIII, launched by Teva Pharmaceuticals in 2019, had an annual sale of around $911 million only in the U.S.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Androgens and Anabolic Steroids Market Report 2023.
Key Insights from Androgens and Anabolic Steroids Market Report
As per Cognitive Market Research's latest published report, the Global Androgens and Anabolic Steroids market size was $52.63 Billion in 2022 and it is forecasted to reach $124.18 Billion by 2030. Androgens and Anabolic Steroids Industry's Compound Annual Growth Rate will be 10.4% from 2023 to 2030.
Androgens and Anabolic Steroids Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Androgens and Anabolic Steroids Market Report Description
Androgens and anabolic steroids are the synthetic derivative of testosterone hormone. Testosterone is a male sex hormone that plays crucial role in growth and reproduction process in an individual. Anabolic steroids are used in the treatment of hormonal problems, such as delayed puberty in males or loss of muscle caused by diseases like cancer or HIV. However, many people illegally use these steroids in building muscles and improve their athletic performance. Long-term use of these steroids may have adverse effects on heart, liver, kidneys, etc. Androgens and anabolic steroids market provides analysis of differnt type and application on the regional level.
Market Dynamics:
- Steep growth in the prevalence of hypogonadism:
Hypogonadism is an abnormal condition in which little or no hormone is produced by the testes or ovaries. It results in infertility and an increased risk of osteoporosis. Primary factor responsible for the rising occurrence of hypogonadism is the surging geriatric population across the globe. Hypogonadism in men, is a characterized by decreased libido, erectile dysfunction, decreased volume of ejaculate, decreased bone density, among others. Hypogonadism in male and diseases, such as type 2 diabetes mellitus, obesity, cardiovascular disease, and osteoporosis appear closely connected.
Moreover, change in lifestyle, unhealthy habits of smoking and consuming alcohol along with stressful life has also increased the risk factor for hormonal problems among people of age group 25 to 40. Androgens and anabolic steroids are the synthetic derivatives of testosterone which are used in the treatment of hypogonadism to enhance the overall functionality of reproductive organs in an individual.
Restraining Factor:
- Adverse effects of steroids, if used for the long-term:
Prolonged use of AAS may cause damage to the immune system. The common side effect associated with AAS is elevated blood pressure, especially in those with pre-existing hypertension. Studies have shown that people with long-term use of steroids are more prone to cardiological disorders.
Other associated side effects are acne, seborrhoea, excessive body hair growth, androgenic alopecia, menstrual disturbances, many other. Thus, androgens and anabolic steroids, if not used properly may cause adverse effects on an individual, hindering its growth across the globe.
Current Trends on Androgens and Anabolic Steroids:
- High use of internet:
Mounting use of internet has been observed as a key aspect for facilitating use of AAS. Use of AAS among young men intent on increasing muscularity is highly stimulated due to the influence through online platforms. Further, easy accessibility regarding the information based on AAS through online channel has increased the demand for androgens and anabolic steroids among young population.
Impact of COVID-19 pandemic on Androgens and Anabolic Steroids Market:
Advent of COVID-19 had shown negative effect on the revenue generated from androgens and anabolic steroids market. This was majorly due to the disruption in supply chain of raw materials and end-products. Furthermore R&D activities has also been hindered due to the unavailability of researchers during the pandemic.
Base Year | 2022 |
Historical Data Time Period | 2018-2022 |
Forecast Period | 2023-2030 |
Report Edition | 7th Edition (2023) |
Last Update | Last Updated In April 2023 |
Next Report Edition | June 2023 (Pre-Booking Available) |
Market Forecast/Projection Time Period | 2023-2030 |
Report Format | PDF | PPT | Excel | Word | Bi |
Report ID | CMR460133 |
Androgens and Anabolic Steroids Market Report 2023 (Global Edition) Table of Content differs according to the user License selection. Current Displayed TOC is for the Single User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report. Specific section/s of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
- 1.1 Global Androgens and Anabolic Steroids Industry Introduction
- 1.2 Objectives of the Study
- 1.3 USP of the Report
- 1.4 Who is this report for?
- 1.5 Designing of Market Scope
- 1.5.1 Androgens and Anabolic Steroids Market Segmentation
- 1.5.1 Androgens and Anabolic Steroids Market Regional Fragmentation
- 1.5.1 Androgens and Anabolic Steroids Market Players
- 1.6 Report Duration
- 1.7 List of Stakeholders
- 2.1 Androgens and Anabolic Steroids Market Report 2023 Research Methodology
- 2.2 Systematic Research Approach
- 2.2.1 Primary Research
- 2.2.1.1 Key Data from Primary
- 2.2.1.2 Primary Interviews with Experts
- 2.2.1.3 Key Industry Insights
- 2.2.1.4 Questionnaire
At Cognitive Market Research, we have designed questionnaire focused on Androgens and Anabolic Steroids Market for the statistical study. This questionnaire is the key part of our research methodology which is shared with number of Androgens and Anabolic Steroids industry experts of entire value chain, located across the globe. This study help us to gather accurate quantitative and qualitative data for the final report.
- 2.2.1.5 Breakdown of Primaries
- 2.2.2 Secondary Research
- 2.2.2.1 Key Data from Secondary
- 2.2.2.2 Paid Sources
- 2.2.2.3 Public Sources
- 2.2.1 Primary Research
- 2.3 Market Size Estimation
- 2.3.1 Top-Down Approach
- 2.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 2.3.1 Bottom-UP Approach
- 2.3.1.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 2.3.1 Top-Down Approach
- 2.4 Market Breakdown and Data Triangulation
- 2.5 Research Assumptions
- 3.1 Global Androgens and Anabolic Steroids Market Size 2018 – 2030, (USD Million)
- 3.2 Global Androgens and Anabolic Steroids Value, Absolute & Opportunity Analysis
- 3.3 Global Androgens and Anabolic Steroids Market Y-o-Y Growth Rate Projection by Region (2023 - 2030)
- 3.4 Global Androgens and Anabolic Steroids Market Statistics 2022: Snapshot
- 4.1 Androgens and Anabolic Steroids Introduction
- 4.2 Global Androgens and Anabolic Steroids Market Statistics by Regions (2018-2030)
- 4.2.1 North America Androgens and Anabolic Steroids Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.2 Europe Androgens and Anabolic Steroids Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.3 Asia Pacific Androgens and Anabolic Steroids Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.4 Latin America Androgens and Anabolic Steroids Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.5 Middle East and Africa Androgens and Anabolic Steroids Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.3 Global Androgens and Anabolic Steroids Market Size (2018-2030)
- 4.3.1 Global Androgens and Anabolic Steroids Revenue Status and Outlook (2018-2030)
- 4.4 Global Androgens and Anabolic Steroids Market Price Analysis by Regions (2018-2030)
- 5.1 Global Androgens and Anabolic Steroids Market Revenue and Share by Manufacturers (2018-2022)
- 5.2 Global Androgens and Anabolic Steroids Industry Mergers and Acquisition Analysis
- 5.3 Global Androgens and Anabolic Steroids New Launches Analysis
- 5.4 Company Categorization
- 5.5 Global Androgens and Anabolic Steroids Top Winning Strategies, by Manufacturers (2018-2022)
- 7.1 Androgens and Anabolic Steroids Industrial Dynamics
- 7.1.1 Global Androgens and Anabolic Steroids Market Drivers
- 7.1.2 Global Androgens and Anabolic Steroids Market Restrains
- 7.1.3 Global Androgens and Anabolic Steroids Market Opportunities
- 7.1.4 Global Androgens and Anabolic Steroids Market Trends
- 7.2 Androgens and Anabolic Steroids Market Attractiveness Analysis
- 7.1.1 Market Attractiveness Analysis by Type Segment
- 7.1.2 Market Attractiveness Analysis by Application Segment
- 7.3 PESTEL Analysis for Androgens and Anabolic Steroids Market
- 7.3.1 Political Factors
- 7.3.2 Economic Factors
- 7.3.3 Social Factors
- 7.3.4 Technological Factors
- 7.3.5 Legal Factors
- 7.3.6 Environmental Factors
- 7.4 Porter’s Five Forces Analysis for Androgens and Anabolic Steroids Market
- 7.4.1 Bargaining Power of Suppliers
- 7.4.2 Bargaining Power of Buyers
- 7.4.3 Threat of Substitutes
- 7.4.4 Threat of New Entrants
- 7.4.5 Degree of Competition
- 7.5 COVID-19 Impact on Androgens and Anabolic Steroids Industry
- 7.4.1 Overall Impact of COVID-19 on Androgens and Anabolic Steroids Industry
- 7.4.2 Post COVID-19 Impact and Recovery Analysis
- 7.4.3 Influencing Factors
- 7.6 Consumer Preference Analysis for Androgens and Anabolic Steroids Market
- 7.7 Patent Analysis of Androgens and Anabolic Steroids
- 7.8 Androgens and Anabolic Steroids Industrial Chain Analysis
- 7.9 Manufacturing Cost Analysis
- 8.1 F. Hoffmann-La Roche Ltd.
- 8.1.1 F. Hoffmann-La Roche Ltd. Company Basic Information, and Sales Area
- 8.1.2 F. Hoffmann-La Roche Ltd. Business Segment/ Overview
- 8.1.3 F. Hoffmann-La Roche Ltd. Financials
- 8.1.3.1 Investment in Research and Development
- 8.1.3.2 F. Hoffmann-La Roche Ltd. Sales Revenue (2018-2022)
- 8.1.3.3 F. Hoffmann-La Roche Ltd. Market Share (2018-2022)
- 8.1.4 F. Hoffmann-La Roche Ltd. Recent Developments
- 8.1.5 F. Hoffmann-La Roche Ltd. Business Strategy
- 8.1.6 F. Hoffmann-La Roche Ltd. Management Change
- 8.1.7 F. Hoffmann-La Roche Ltd.
SWOT Analysis
- 8.1.7.1 Strength
- 8.1.7.2 Weakness
- 8.1.7.3 Opportunity
- 8.1.7.4 Threats
- 8.1.8 F. Hoffmann-La Roche Ltd. COVID-19 Impact Analysis
- 8.2 Mylan N.V.
- 8.2.1 Mylan N.V. Company Basic Information, and Sales Area
- 8.2.2 Mylan N.V. Business Segment/ Overview
- 8.2.3 Mylan N.V. Financials
- 8.2.3.1 Investment in Research and Development
- 8.2.3.2 Mylan N.V. Sales Revenue (2018-2022)
- 8.2.3.3 Mylan N.V. Market Share (2018-2022)
- 8.2.4 Mylan N.V. Recent Developments
- 8.2.5 Mylan N.V. Business Strategy
- 8.2.6 Mylan N.V. Management Change
- 8.2.7 Mylan N.V.
SWOT Analysis
- 8.2.7.1 Strength
- 8.2.7.2 Weakness
- 8.2.7.3 Opportunity
- 8.2.7.4 Threats
- 8.2.8 Mylan N.V. COVID-19 Impact Analysis
- 8.3 Teva Pharmaceutical Industries Ltd.
- 8.3.1 Teva Pharmaceutical Industries Ltd. Company Basic Information, and Sales Area
- 8.3.2 Teva Pharmaceutical Industries Ltd. Business Segment/ Overview
- 8.3.3 Teva Pharmaceutical Industries Ltd. Financials
- 8.3.3.1 Investment in Research and Development
- 8.3.3.2 Teva Pharmaceutical Industries Ltd. Sales Revenue (2018-2022)
- 8.3.3.3 Teva Pharmaceutical Industries Ltd. Market Share (2018-2022)
- 8.3.4 Teva Pharmaceutical Industries Ltd. Recent Developments
- 8.3.5 Teva Pharmaceutical Industries Ltd. Business Strategy
- 8.3.6 Teva Pharmaceutical Industries Ltd. Management Change
- 8.3.7 Teva Pharmaceutical Industries Ltd.
SWOT Analysis
- 8.3.7.1 Strength
- 8.3.7.2 Weakness
- 8.3.7.3 Opportunity
- 8.3.7.4 Threats
- 8.3.8 Teva Pharmaceutical Industries Ltd. COVID-19 Impact Analysis
- 8.4 Pfizer Inc.
- 8.4.1 Pfizer Inc. Company Basic Information, and Sales Area
- 8.4.2 Pfizer Inc. Business Segment/ Overview
- 8.4.3 Pfizer Inc. Financials
- 8.4.3.1 Investment in Research and Development
- 8.4.3.2 Pfizer Inc. Sales Revenue (2018-2022)
- 8.4.3.3 Pfizer Inc. Market Share (2018-2022)
- 8.4.4 Pfizer Inc. Recent Developments
- 8.4.5 Pfizer Inc. Business Strategy
- 8.4.6 Pfizer Inc. Management Change
- 8.4.7 Pfizer Inc.
SWOT Analysis
- 8.4.7.1 Strength
- 8.4.7.2 Weakness
- 8.4.7.3 Opportunity
- 8.4.7.4 Threats
- 8.4.8 Pfizer Inc. COVID-19 Impact Analysis
- 8.5 Sanofi
- 8.5.1 Sanofi Company Basic Information, and Sales Area
- 8.5.2 Sanofi Business Segment/ Overview
- 8.5.3 Sanofi Financials
- 8.5.3.1 Investment in Research and Development
- 8.5.3.2 Sanofi Sales Revenue (2018-2022)
- 8.5.3.3 Sanofi Market Share (2018-2022)
- 8.5.4 Sanofi Recent Developments
- 8.5.5 Sanofi Business Strategy
- 8.5.6 Sanofi Management Change
- 8.5.7 Sanofi
SWOT Analysis
- 8.5.7.1 Strength
- 8.5.7.2 Weakness
- 8.5.7.3 Opportunity
- 8.5.7.4 Threats
- 8.5.8 Sanofi COVID-19 Impact Analysis
- 8.6 GSK
- 8.6.1 GSK Company Basic Information, and Sales Area
- 8.6.2 GSK Business Segment/ Overview
- 8.6.3 GSK Financials
- 8.6.3.1 Investment in Research and Development
- 8.6.3.2 GSK Sales Revenue (2018-2022)
- 8.6.3.3 GSK Market Share (2018-2022)
- 8.6.4 GSK Recent Developments
- 8.6.5 GSK Business Strategy
- 8.6.6 GSK Management Change
- 8.6.7 GSK
SWOT Analysis
- 8.6.7.1 Strength
- 8.6.7.2 Weakness
- 8.6.7.3 Opportunity
- 8.6.7.4 Threats
- 8.6.8 GSK COVID-19 Impact Analysis
- 8.7 Novartis AG
- 8.7.1 Novartis AG Company Basic Information, and Sales Area
- 8.7.2 Novartis AG Business Segment/ Overview
- 8.7.3 Novartis AG Financials
- 8.7.3.1 Investment in Research and Development
- 8.7.3.2 Novartis AG Sales Revenue (2018-2022)
- 8.7.3.3 Novartis AG Market Share (2018-2022)
- 8.7.4 Novartis AG Recent Developments
- 8.7.5 Novartis AG Business Strategy
- 8.7.6 Novartis AG Management Change
- 8.7.7 Novartis AG
SWOT Analysis
- 8.7.7.1 Strength
- 8.7.7.2 Weakness
- 8.7.7.3 Opportunity
- 8.7.7.4 Threats
- 8.7.8 Novartis AG COVID-19 Impact Analysis
- 8.8 AstraZeneca
- 8.8.1 AstraZeneca Company Basic Information, and Sales Area
- 8.8.2 AstraZeneca Business Segment/ Overview
- 8.8.3 AstraZeneca Financials
- 8.8.3.1 Investment in Research and Development
- 8.8.3.2 AstraZeneca Sales Revenue (2018-2022)
- 8.8.3.3 AstraZeneca Market Share (2018-2022)
- 8.8.4 AstraZeneca Recent Developments
- 8.8.5 AstraZeneca Business Strategy
- 8.8.6 AstraZeneca Management Change
- 8.8.7 AstraZeneca
SWOT Analysis
- 8.8.7.1 Strength
- 8.8.7.2 Weakness
- 8.8.7.3 Opportunity
- 8.8.7.4 Threats
- 8.8.8 AstraZeneca COVID-19 Impact Analysis
- 8.9 Johnson & Johnson Private Limited
- 8.9.1 Johnson & Johnson Private Limited Company Basic Information, and Sales Area
- 8.9.2 Johnson & Johnson Private Limited Business Segment/ Overview
- 8.9.3 Johnson & Johnson Private Limited Financials
- 8.9.3.1 Investment in Research and Development
- 8.9.3.2 Johnson & Johnson Private Limited Sales Revenue (2018-2022)
- 8.9.3.3 Johnson & Johnson Private Limited Market Share (2018-2022)
- 8.9.4 Johnson & Johnson Private Limited Recent Developments
- 8.9.5 Johnson & Johnson Private Limited Business Strategy
- 8.9.6 Johnson & Johnson Private Limited Management Change
- 8.9.7 Johnson & Johnson Private Limited
SWOT Analysis
- 8.9.7.1 Strength
- 8.9.7.2 Weakness
- 8.9.7.3 Opportunity
- 8.9.7.4 Threats
- 8.9.8 Johnson & Johnson Private Limited COVID-19 Impact Analysis
- 8.10 Dr. Reddy’s Laboratories Ltd.
- 8.10.1 Dr. Reddy’s Laboratories Ltd. Company Basic Information, and Sales Area
- 8.10.2 Dr. Reddy’s Laboratories Ltd. Business Segment/ Overview
- 8.10.3 Dr. Reddy’s Laboratories Ltd. Financials
- 8.10.3.1 Investment in Research and Development
- 8.10.3.2 Dr. Reddy’s Laboratories Ltd. Sales Revenue (2018-2022)
- 8.10.3.3 Dr. Reddy’s Laboratories Ltd. Market Share (2018-2022)
- 8.10.4 Dr. Reddy’s Laboratories Ltd. Recent Developments
- 8.10.5 Dr. Reddy’s Laboratories Ltd. Business Strategy
- 8.10.6 Dr. Reddy’s Laboratories Ltd. Management Change
- 8.10.7 Dr. Reddy’s Laboratories Ltd.
SWOT Analysis
- 8.10.7.1 Strength
- 8.10.7.2 Weakness
- 8.10.7.3 Opportunity
- 8.10.7.4 Threats
- 8.10.8 Dr. Reddy’s Laboratories Ltd. COVID-19 Impact Analysis
- 8.11 Lupin
- 8.11.1 Lupin Company Basic Information, and Sales Area
- 8.11.2 Lupin Business Segment/ Overview
- 8.11.3 Lupin Financials
- 8.11.3.1 Investment in Research and Development
- 8.11.3.2 Lupin Sales Revenue (2018-2022)
- 8.11.3.3 Lupin Market Share (2018-2022)
- 8.11.4 Lupin Recent Developments
- 8.11.5 Lupin Business Strategy
- 8.11.6 Lupin Management Change
- 8.11.7 Lupin
SWOT Analysis
- 8.11.7.1 Strength
- 8.11.7.2 Weakness
- 8.11.7.3 Opportunity
- 8.11.7.4 Threats
- 8.11.8 Lupin COVID-19 Impact Analysis
- 8.12 Cipla Inc.
- 8.12.1 Cipla Inc. Company Basic Information, and Sales Area
- 8.12.2 Cipla Inc. Business Segment/ Overview
- 8.12.3 Cipla Inc. Financials
- 8.12.3.1 Investment in Research and Development
- 8.12.3.2 Cipla Inc. Sales Revenue (2018-2022)
- 8.12.3.3 Cipla Inc. Market Share (2018-2022)
- 8.12.4 Cipla Inc. Recent Developments
- 8.12.5 Cipla Inc. Business Strategy
- 8.12.6 Cipla Inc. Management Change
- 8.12.7 Cipla Inc.
SWOT Analysis
- 8.12.7.1 Strength
- 8.12.7.2 Weakness
- 8.12.7.3 Opportunity
- 8.12.7.4 Threats
- 8.12.8 Cipla Inc. COVID-19 Impact Analysis
- 8.13 Eli Lilly
- 8.13.1 Eli Lilly Company Basic Information, and Sales Area
- 8.13.2 Eli Lilly Business Segment/ Overview
- 8.13.3 Eli Lilly Financials
- 8.13.3.1 Investment in Research and Development
- 8.13.3.2 Eli Lilly Sales Revenue (2018-2022)
- 8.13.3.3 Eli Lilly Market Share (2018-2022)
- 8.13.4 Eli Lilly Recent Developments
- 8.13.5 Eli Lilly Business Strategy
- 8.13.6 Eli Lilly Management Change
- 8.13.7 Eli Lilly
SWOT Analysis
- 8.13.7.1 Strength
- 8.13.7.2 Weakness
- 8.13.7.3 Opportunity
- 8.13.7.4 Threats
- 8.13.8 Eli Lilly COVID-19 Impact Analysis
- 8.14 AbbVie Inc.
- 8.14.1 AbbVie Inc. Company Basic Information, and Sales Area
- 8.14.2 AbbVie Inc. Business Segment/ Overview
- 8.14.3 AbbVie Inc. Financials
- 8.14.3.1 Investment in Research and Development
- 8.14.3.2 AbbVie Inc. Sales Revenue (2018-2022)
- 8.14.3.3 AbbVie Inc. Market Share (2018-2022)
- 8.14.4 AbbVie Inc. Recent Developments
- 8.14.5 AbbVie Inc. Business Strategy
- 8.14.6 AbbVie Inc. Management Change
- 8.14.7 AbbVie Inc.
SWOT Analysis
- 8.14.7.1 Strength
- 8.14.7.2 Weakness
- 8.14.7.3 Opportunity
- 8.14.7.4 Threats
- 8.14.8 AbbVie Inc. COVID-19 Impact Analysis
- 8.15 Others
- 8.15.1 Others Company Basic Information, and Sales Area
- 8.15.2 Others Business Segment/ Overview
- 8.15.3 Others Financials
- 8.15.3.1 Investment in Research and Development
- 8.15.3.2 Others Sales Revenue (2018-2022)
- 8.15.3.3 Others Market Share (2018-2022)
- 8.15.4 Others Recent Developments
- 8.15.5 Others Business Strategy
- 8.15.6 Others Management Change
- 8.15.7 Others SWOT Analysis
- 8.15.7.1 Strength
- 8.15.7.2 Weakness
- 8.15.7.3 Opportunity
- 8.15.7.4 Threats
- 8.15.8 Others COVID-19 Impact Analysis
- 9.1 Detailed Qualitative Analysis
- 9.2 Global Androgens and Anabolic Steroids Revenue and Share (%) by Modes of Administration (2018-2030)
- 9.2.1 Oral
Market Size
- 9.2.1.1 Global Oral Market Share and Revenue (USD Million) for 2018-2030
- 9.2.1.2 Androgens and Anabolic Steroids Market for Oral , by Country (2021 Vs 2024)
- 9.2.2 Injectables
Market Size
- 9.2.2.1 Global Injectables Market Share and Revenue (USD Million) for 2018-2030
- 9.2.2.2 Androgens and Anabolic Steroids Market for Injectables , by Country (2021 Vs 2024)
- 9.2.3 Topical
Market Size
- 9.2.3.1 Global Topical Market Share and Revenue (USD Million) for 2018-2030
- 9.2.3.2 Androgens and Anabolic Steroids Market for Topical , by Country (2021 Vs 2024)
- 9.2.4 Others Market Size
- 9.2.4.1 Global Others Market Share and Revenue (USD Million) for 2018-2030
- 9.2.4.2 Androgens and Anabolic Steroids Market for Others, by Country (2021 Vs 2024)
- 9.2.1 Oral
Market Size
- 10.1 Detailed Qualitative Analysis
- 10.2 Global Androgens and Anabolic Steroids Revenue and Share (%) by Application (2018-2030)
- 10.2.1 Anabolic
Market Size
- 10.2.1.1 Global Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 10.2.1.2 Androgens and Anabolic Steroids Market for Anabolic , by Country (2021 Vs 2024)
- 10.2.2 Androgenic
Market Size
- 10.2.2.1 Global Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 10.2.2.2 Androgens and Anabolic Steroids Market for Androgenic , by Country (2021 Vs 2024)
- 10.2.3 Others Market Size
- 10.2.3.1 Global Others Market Share and Revenue (USD Million) for 2018-2030
- 10.2.3.2 Androgens and Anabolic Steroids Market for Others, by Country (2021 Vs 2024)
- 10.2.1 Anabolic
Market Size
- 11.1 Detailed Qualitative Analysis
- 11.2 Global Androgens and Anabolic Steroids Revenue and Share (%) by Ingredients (2018-2030)
- 11.2.1 Protein
Market Size
- 11.2.1.1 Global Protein Market Share and Revenue (USD Million) for 2018-2030
- 11.2.1.2 Androgens and Anabolic Steroids Market for Protein , by Country (2021 Vs 2024)
- 11.2.2 Beta-alanine
Market Size
- 11.2.2.1 Global Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 11.2.2.2 Androgens and Anabolic Steroids Market for Beta-alanine , by Country (2021 Vs 2024)
- 11.2.3 Creatine
Market Size
- 11.2.3.1 Global Creatine Market Share and Revenue (USD Million) for 2018-2030
- 11.2.3.2 Androgens and Anabolic Steroids Market for Creatine , by Country (2021 Vs 2024)
- 11.2.4 Caffeine
Market Size
- 11.2.4.1 Global Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 11.2.4.2 Androgens and Anabolic Steroids Market for Caffeine , by Country (2021 Vs 2024)
- 11.2.5 Others Market Size
- 11.2.5.1 Global Others Market Share and Revenue (USD Million) for 2018-2030
- 11.2.5.2 Androgens and Anabolic Steroids Market for Others, by Country (2021 Vs 2024)
- 11.2.1 Protein
Market Size
- 12.1 Detailed Qualitative Analysis
- 12.2 Global Androgens and Anabolic Steroids Revenue and Share (%) by Distribution Channel (2018-2030)
- 12.2.1 Offline
Market Size
- 12.2.1.1 Global Offline Market Share and Revenue (USD Million) for 2018-2030
- 12.2.1.2 Androgens and Anabolic Steroids Market for Offline , by Country (2021 Vs 2024)
- 12.2.2 Online Market Size
- 12.2.2.1 Global Online Market Share and Revenue (USD Million) for 2018-2030
- 12.2.2.2 Androgens and Anabolic Steroids Market for Online, by Country (2021 Vs 2024)
- 12.2.1 Offline
Market Size
- 13.1 Detailed Qualitative Analysis
- 13.2 Global Androgens and Anabolic Steroids Market Revenue by Region (2018-2030)
- 13.3 Global Androgens and Anabolic Steroids Market Share (%) by Region (2018-2030)
- 14.1 North America
- 14.1.1 North America Androgens and Anabolic Steroids Market Trends and Analysis
- 14.1.2 North America Androgens and Anabolic Steroids Market by Country, 2018-2030
- 14.1.3 North America Androgens and Anabolic Steroids Market Attractiveness Analysis by Country
- 14.2 North America Androgens and Anabolic Steroids Market Size (2018-2030)
- 14.2.1 North America Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 14.2.1.1 Oral
- 14.2.1.1.1 North America Oral Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Injectables
- 14.2.1.2.1 North America Injectables Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Topical
- 14.2.1.3.1 North America Topical Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Others
- 14.2.1.4.1 North America Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Oral
- 14.2.2 North America Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 14.2.2.1 Anabolic
- 14.2.2.1.1 North America Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Androgenic
- 14.2.2.2.1 North America Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Others
- 14.2.2.3.1 North America Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Anabolic
- 14.2.3 North America Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 14.2.3.1 Protein
- 14.2.3.1.1 North America Protein Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Beta-alanine
- 14.2.3.2.1 North America Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Creatine
- 14.2.3.3.1 North America Creatine Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Caffeine
- 14.2.3.4.1 North America Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.5 Others
- 14.2.3.5.1 North America Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 Protein
- 14.2.4 North America Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 14.2.4.1 Offline
- 14.2.4.1.1 North America Offline Market Share and Revenue (USD Million) for 2018-2030
- 14.2.4.2 Online
- 14.2.4.2.1 North America Online Market Share and Revenue (USD Million) for 2018-2030
- 14.2.4.1 Offline
- 14.2.1 North America Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 14.3 United States Androgens and Anabolic Steroids Market Size (2018-2030)
- 14.3.1 United States Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 14.3.1.1 Oral
- 14.3.1.1.1 United States Oral Market Share and Revenue (USD Million) for 2018-2030
- 14.3.1.2 Injectables
- 14.3.1.2.1 United States Injectables Market Share and Revenue (USD Million) for 2018-2030
- 14.3.1.3 Topical
- 14.3.1.3.1 United States Topical Market Share and Revenue (USD Million) for 2018-2030
- 14.3.1.4 Others
- 14.3.1.4.1 United States Others Market Share and Revenue (USD Million) for 2018-2030
- 14.3.1.1 Oral
- 14.3.2 United States Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 14.3.2.1 Anabolic
- 14.3.2.1.1 United States Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 14.3.2.2 Androgenic
- 14.3.2.2.1 United States Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 14.3.2.3 Others
- 14.3.2.3.1 United States Others Market Share and Revenue (USD Million) for 2018-2030
- 14.3.2.1 Anabolic
- 14.3.3 United States Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 14.3.3.1 Protein
- 14.3.3.1.1 United States Protein Market Share and Revenue (USD Million) for 2018-2030
- 14.3.3.2 Beta-alanine
- 14.3.3.2.1 United States Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 14.3.3.3 Creatine
- 14.3.3.3.1 United States Creatine Market Share and Revenue (USD Million) for 2018-2030
- 14.3.3.4 Caffeine
- 14.3.3.4.1 United States Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 14.3.3.5 Others
- 14.3.3.5.1 United States Others Market Share and Revenue (USD Million) for 2018-2030
- 14.3.3.1 Protein
- 14.3.4 United States Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 14.3.4.1 Offline
- 14.3.4.1.1 United States Offline Market Share and Revenue (USD Million) for 2018-2030
- 14.3.4.2 Online
- 14.3.4.2.1 United States Online Market Share and Revenue (USD Million) for 2018-2030
- 14.3.4.1 Offline
- 14.3.1 United States Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 14.4 Canada Androgens and Anabolic Steroids Market Size (2018-2030)
- 14.4.1 Canada Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 14.4.1.1 Oral
- 14.4.1.1.1 Canada Oral Market Share and Revenue (USD Million) for 2018-2030
- 14.4.1.2 Injectables
- 14.4.1.2.1 Canada Injectables Market Share and Revenue (USD Million) for 2018-2030
- 14.4.1.3 Topical
- 14.4.1.3.1 Canada Topical Market Share and Revenue (USD Million) for 2018-2030
- 14.4.1.4 Others
- 14.4.1.4.1 Canada Others Market Share and Revenue (USD Million) for 2018-2030
- 14.4.1.1 Oral
- 14.4.2 Canada Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 14.4.2.1 Anabolic
- 14.4.2.1.1 Canada Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 14.4.2.2 Androgenic
- 14.4.2.2.1 Canada Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 14.4.2.3 Others
- 14.4.2.3.1 Canada Others Market Share and Revenue (USD Million) for 2018-2030
- 14.4.2.1 Anabolic
- 14.4.3 Canada Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 14.4.3.1 Protein
- 14.4.3.1.1 Canada Protein Market Share and Revenue (USD Million) for 2018-2030
- 14.4.3.2 Beta-alanine
- 14.4.3.2.1 Canada Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 14.4.3.3 Creatine
- 14.4.3.3.1 Canada Creatine Market Share and Revenue (USD Million) for 2018-2030
- 14.4.3.4 Caffeine
- 14.4.3.4.1 Canada Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 14.4.3.5 Others
- 14.4.3.5.1 Canada Others Market Share and Revenue (USD Million) for 2018-2030
- 14.4.3.1 Protein
- 14.4.4 Canada Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 14.4.4.1 Offline
- 14.4.4.1.1 Canada Offline Market Share and Revenue (USD Million) for 2018-2030
- 14.4.4.2 Online
- 14.4.4.2.1 Canada Online Market Share and Revenue (USD Million) for 2018-2030
- 14.4.4.1 Offline
- 14.4.1 Canada Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 14.5 Mexico Androgens and Anabolic Steroids Market Size (2018-2030)
- 14.5.1 Mexico Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 14.5.1.1 Oral
- 14.5.1.1.1 Mexico Oral Market Share and Revenue (USD Million) for 2018-2030
- 14.5.1.2 Injectables
- 14.5.1.2.1 Mexico Injectables Market Share and Revenue (USD Million) for 2018-2030
- 14.5.1.3 Topical
- 14.5.1.3.1 Mexico Topical Market Share and Revenue (USD Million) for 2018-2030
- 14.5.1.4 Others
- 14.5.1.4.1 Mexico Others Market Share and Revenue (USD Million) for 2018-2030
- 14.5.1.1 Oral
- 14.5.2 Mexico Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 14.5.2.1 Anabolic
- 14.5.2.1.1 Mexico Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 14.5.2.2 Androgenic
- 14.5.2.2.1 Mexico Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 14.5.2.3 Others
- 14.5.2.3.1 Mexico Others Market Share and Revenue (USD Million) for 2018-2030
- 14.5.2.1 Anabolic
- 14.5.3 Mexico Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 14.5.3.1 Protein
- 14.5.3.1.1 Mexico Protein Market Share and Revenue (USD Million) for 2018-2030
- 14.5.3.2 Beta-alanine
- 14.5.3.2.1 Mexico Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 14.5.3.3 Creatine
- 14.5.3.3.1 Mexico Creatine Market Share and Revenue (USD Million) for 2018-2030
- 14.5.3.4 Caffeine
- 14.5.3.4.1 Mexico Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 14.5.3.5 Others
- 14.5.3.5.1 Mexico Others Market Share and Revenue (USD Million) for 2018-2030
- 14.5.3.1 Protein
- 14.5.4 Mexico Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 14.5.4.1 Offline
- 14.5.4.1.1 Mexico Offline Market Share and Revenue (USD Million) for 2018-2030
- 14.5.4.2 Online
- 14.5.4.2.1 Mexico Online Market Share and Revenue (USD Million) for 2018-2030
- 14.5.4.1 Offline
- 14.5.1 Mexico Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.1 Europe
- 15.1.1 Europe Androgens and Anabolic Steroids Market Trends and Analysis
- 15.1.2 Europe Androgens and Anabolic Steroids Market by Country, 2018-2030
- 15.1.3 Europe Androgens and Anabolic Steroids Market Attractiveness Analysis by Country
- 15.2 Europe Androgens and Anabolic Steroids Market Size (2018-2030)
- 15.2.1 Europe Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.2.1.1 Oral
- 15.2.1.1.1 Europe Oral Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Injectables
- 15.2.1.2.1 Europe Injectables Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Topical
- 15.2.1.3.1 Europe Topical Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Others
- 15.2.1.4.1 Europe Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Oral
- 15.2.2 Europe Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 15.2.2.1 Anabolic
- 15.2.2.1.1 Europe Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Androgenic
- 15.2.2.2.1 Europe Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Others
- 15.2.2.3.1 Europe Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Anabolic
- 15.2.3 Europe Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 15.2.3.1 Protein
- 15.2.3.1.1 Europe Protein Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Beta-alanine
- 15.2.3.2.1 Europe Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Creatine
- 15.2.3.3.1 Europe Creatine Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Caffeine
- 15.2.3.4.1 Europe Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.5 Others
- 15.2.3.5.1 Europe Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 Protein
- 15.2.4 Europe Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 15.2.4.1 Offline
- 15.2.4.1.1 Europe Offline Market Share and Revenue (USD Million) for 2018-2030
- 15.2.4.2 Online
- 15.2.4.2.1 Europe Online Market Share and Revenue (USD Million) for 2018-2030
- 15.2.4.1 Offline
- 15.2.1 Europe Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.3 United Kingdom Androgens and Anabolic Steroids Market Size (2018-2030)
- 15.3.1 United Kingdom Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.3.1.1 Oral
- 15.3.1.1.1 United Kingdom Oral Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.2 Injectables
- 15.3.1.2.1 United Kingdom Injectables Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.3 Topical
- 15.3.1.3.1 United Kingdom Topical Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.4 Others
- 15.3.1.4.1 United Kingdom Others Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.1 Oral
- 15.3.2 United Kingdom Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 15.3.2.1 Anabolic
- 15.3.2.1.1 United Kingdom Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 15.3.2.2 Androgenic
- 15.3.2.2.1 United Kingdom Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 15.3.2.3 Others
- 15.3.2.3.1 United Kingdom Others Market Share and Revenue (USD Million) for 2018-2030
- 15.3.2.1 Anabolic
- 15.3.3 United Kingdom Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 15.3.3.1 Protein
- 15.3.3.1.1 United Kingdom Protein Market Share and Revenue (USD Million) for 2018-2030
- 15.3.3.2 Beta-alanine
- 15.3.3.2.1 United Kingdom Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 15.3.3.3 Creatine
- 15.3.3.3.1 United Kingdom Creatine Market Share and Revenue (USD Million) for 2018-2030
- 15.3.3.4 Caffeine
- 15.3.3.4.1 United Kingdom Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 15.3.3.5 Others
- 15.3.3.5.1 United Kingdom Others Market Share and Revenue (USD Million) for 2018-2030
- 15.3.3.1 Protein
- 15.3.4 United Kingdom Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 15.3.4.1 Offline
- 15.3.4.1.1 United Kingdom Offline Market Share and Revenue (USD Million) for 2018-2030
- 15.3.4.2 Online
- 15.3.4.2.1 United Kingdom Online Market Share and Revenue (USD Million) for 2018-2030
- 15.3.4.1 Offline
- 15.3.1 United Kingdom Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.4 France Androgens and Anabolic Steroids Market Size (2018-2030)
- 15.4.1 France Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.4.1.1 Oral
- 15.4.1.1.1 France Oral Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.2 Injectables
- 15.4.1.2.1 France Injectables Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.3 Topical
- 15.4.1.3.1 France Topical Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.4 Others
- 15.4.1.4.1 France Others Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.1 Oral
- 15.4.2 France Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 15.4.2.1 Anabolic
- 15.4.2.1.1 France Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 15.4.2.2 Androgenic
- 15.4.2.2.1 France Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 15.4.2.3 Others
- 15.4.2.3.1 France Others Market Share and Revenue (USD Million) for 2018-2030
- 15.4.2.1 Anabolic
- 15.4.3 France Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 15.4.3.1 Protein
- 15.4.3.1.1 France Protein Market Share and Revenue (USD Million) for 2018-2030
- 15.4.3.2 Beta-alanine
- 15.4.3.2.1 France Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 15.4.3.3 Creatine
- 15.4.3.3.1 France Creatine Market Share and Revenue (USD Million) for 2018-2030
- 15.4.3.4 Caffeine
- 15.4.3.4.1 France Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 15.4.3.5 Others
- 15.4.3.5.1 France Others Market Share and Revenue (USD Million) for 2018-2030
- 15.4.3.1 Protein
- 15.4.4 France Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 15.4.4.1 Offline
- 15.4.4.1.1 France Offline Market Share and Revenue (USD Million) for 2018-2030
- 15.4.4.2 Online
- 15.4.4.2.1 France Online Market Share and Revenue (USD Million) for 2018-2030
- 15.4.4.1 Offline
- 15.4.1 France Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.5 Germany Androgens and Anabolic Steroids Market Size (2018-2030)
- 15.5.1 Germany Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.5.1.1 Oral
- 15.5.1.1.1 Germany Oral Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.2 Injectables
- 15.5.1.2.1 Germany Injectables Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.3 Topical
- 15.5.1.3.1 Germany Topical Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.4 Others
- 15.5.1.4.1 Germany Others Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.1 Oral
- 15.5.2 Germany Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 15.5.2.1 Anabolic
- 15.5.2.1.1 Germany Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 15.5.2.2 Androgenic
- 15.5.2.2.1 Germany Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 15.5.2.3 Others
- 15.5.2.3.1 Germany Others Market Share and Revenue (USD Million) for 2018-2030
- 15.5.2.1 Anabolic
- 15.5.3 Germany Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 15.5.3.1 Protein
- 15.5.3.1.1 Germany Protein Market Share and Revenue (USD Million) for 2018-2030
- 15.5.3.2 Beta-alanine
- 15.5.3.2.1 Germany Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 15.5.3.3 Creatine
- 15.5.3.3.1 Germany Creatine Market Share and Revenue (USD Million) for 2018-2030
- 15.5.3.4 Caffeine
- 15.5.3.4.1 Germany Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 15.5.3.5 Others
- 15.5.3.5.1 Germany Others Market Share and Revenue (USD Million) for 2018-2030
- 15.5.3.1 Protein
- 15.5.4 Germany Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 15.5.4.1 Offline
- 15.5.4.1.1 Germany Offline Market Share and Revenue (USD Million) for 2018-2030
- 15.5.4.2 Online
- 15.5.4.2.1 Germany Online Market Share and Revenue (USD Million) for 2018-2030
- 15.5.4.1 Offline
- 15.5.1 Germany Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.6 Italy Androgens and Anabolic Steroids Market Size (2018-2030)
- 15.6.1 Italy Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.6.1.1 Oral
- 15.6.1.1.1 Italy Oral Market Share and Revenue (USD Million) for 2018-2030
- 15.6.1.2 Injectables
- 15.6.1.2.1 Italy Injectables Market Share and Revenue (USD Million) for 2018-2030
- 15.6.1.3 Topical
- 15.6.1.3.1 Italy Topical Market Share and Revenue (USD Million) for 2018-2030
- 15.6.1.4 Others
- 15.6.1.4.1 Italy Others Market Share and Revenue (USD Million) for 2018-2030
- 15.6.1.1 Oral
- 15.6.2 Italy Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 15.6.2.1 Anabolic
- 15.6.2.1.1 Italy Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 15.6.2.2 Androgenic
- 15.6.2.2.1 Italy Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 15.6.2.3 Others
- 15.6.2.3.1 Italy Others Market Share and Revenue (USD Million) for 2018-2030
- 15.6.2.1 Anabolic
- 15.6.3 Italy Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 15.6.3.1 Protein
- 15.6.3.1.1 Italy Protein Market Share and Revenue (USD Million) for 2018-2030
- 15.6.3.2 Beta-alanine
- 15.6.3.2.1 Italy Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 15.6.3.3 Creatine
- 15.6.3.3.1 Italy Creatine Market Share and Revenue (USD Million) for 2018-2030
- 15.6.3.4 Caffeine
- 15.6.3.4.1 Italy Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 15.6.3.5 Others
- 15.6.3.5.1 Italy Others Market Share and Revenue (USD Million) for 2018-2030
- 15.6.3.1 Protein
- 15.6.4 Italy Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 15.6.4.1 Offline
- 15.6.4.1.1 Italy Offline Market Share and Revenue (USD Million) for 2018-2030
- 15.6.4.2 Online
- 15.6.4.2.1 Italy Online Market Share and Revenue (USD Million) for 2018-2030
- 15.6.4.1 Offline
- 15.6.1 Italy Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.7 Russia Androgens and Anabolic Steroids Market Size (2018-2030)
- 15.7.1 Russia Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.7.1.1 Oral
- 15.7.1.1.1 Russia Oral Market Share and Revenue (USD Million) for 2018-2030
- 15.7.1.2 Injectables
- 15.7.1.2.1 Russia Injectables Market Share and Revenue (USD Million) for 2018-2030
- 15.7.1.3 Topical
- 15.7.1.3.1 Russia Topical Market Share and Revenue (USD Million) for 2018-2030
- 15.7.1.4 Others
- 15.7.1.4.1 Russia Others Market Share and Revenue (USD Million) for 2018-2030
- 15.7.1.1 Oral
- 15.7.2 Russia Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 15.7.2.1 Anabolic
- 15.7.2.1.1 Russia Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 15.7.2.2 Androgenic
- 15.7.2.2.1 Russia Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 15.7.2.3 Others
- 15.7.2.3.1 Russia Others Market Share and Revenue (USD Million) for 2018-2030
- 15.7.2.1 Anabolic
- 15.7.3 Russia Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 15.7.3.1 Protein
- 15.7.3.1.1 Russia Protein Market Share and Revenue (USD Million) for 2018-2030
- 15.7.3.2 Beta-alanine
- 15.7.3.2.1 Russia Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 15.7.3.3 Creatine
- 15.7.3.3.1 Russia Creatine Market Share and Revenue (USD Million) for 2018-2030
- 15.7.3.4 Caffeine
- 15.7.3.4.1 Russia Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 15.7.3.5 Others
- 15.7.3.5.1 Russia Others Market Share and Revenue (USD Million) for 2018-2030
- 15.7.3.1 Protein
- 15.7.4 Russia Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 15.7.4.1 Offline
- 15.7.4.1.1 Russia Offline Market Share and Revenue (USD Million) for 2018-2030
- 15.7.4.2 Online
- 15.7.4.2.1 Russia Online Market Share and Revenue (USD Million) for 2018-2030
- 15.7.4.1 Offline
- 15.7.1 Russia Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.8 Spain Androgens and Anabolic Steroids Market Size (2018-2030)
- 15.8.1 Spain Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.8.1.1 Oral
- 15.8.1.1.1 Spain Oral Market Share and Revenue (USD Million) for 2018-2030
- 15.8.1.2 Injectables
- 15.8.1.2.1 Spain Injectables Market Share and Revenue (USD Million) for 2018-2030
- 15.8.1.3 Topical
- 15.8.1.3.1 Spain Topical Market Share and Revenue (USD Million) for 2018-2030
- 15.8.1.4 Others
- 15.8.1.4.1 Spain Others Market Share and Revenue (USD Million) for 2018-2030
- 15.8.1.1 Oral
- 15.8.2 Spain Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 15.8.2.1 Anabolic
- 15.8.2.1.1 Spain Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 15.8.2.2 Androgenic
- 15.8.2.2.1 Spain Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 15.8.2.3 Others
- 15.8.2.3.1 Spain Others Market Share and Revenue (USD Million) for 2018-2030
- 15.8.2.1 Anabolic
- 15.8.3 Spain Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 15.8.3.1 Protein
- 15.8.3.1.1 Spain Protein Market Share and Revenue (USD Million) for 2018-2030
- 15.8.3.2 Beta-alanine
- 15.8.3.2.1 Spain Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 15.8.3.3 Creatine
- 15.8.3.3.1 Spain Creatine Market Share and Revenue (USD Million) for 2018-2030
- 15.8.3.4 Caffeine
- 15.8.3.4.1 Spain Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 15.8.3.5 Others
- 15.8.3.5.1 Spain Others Market Share and Revenue (USD Million) for 2018-2030
- 15.8.3.1 Protein
- 15.8.4 Spain Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 15.8.4.1 Offline
- 15.8.4.1.1 Spain Offline Market Share and Revenue (USD Million) for 2018-2030
- 15.8.4.2 Online
- 15.8.4.2.1 Spain Online Market Share and Revenue (USD Million) for 2018-2030
- 15.8.4.1 Offline
- 15.8.1 Spain Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.9 Sweden Androgens and Anabolic Steroids Market Size (2018-2030)
- 15.9.1 Sweden Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.9.1.1 Oral
- 15.9.1.1.1 Sweden Oral Market Share and Revenue (USD Million) for 2018-2030
- 15.9.1.2 Injectables
- 15.9.1.2.1 Sweden Injectables Market Share and Revenue (USD Million) for 2018-2030
- 15.9.1.3 Topical
- 15.9.1.3.1 Sweden Topical Market Share and Revenue (USD Million) for 2018-2030
- 15.9.1.4 Others
- 15.9.1.4.1 Sweden Others Market Share and Revenue (USD Million) for 2018-2030
- 15.9.1.1 Oral
- 15.9.2 Sweden Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 15.9.2.1 Anabolic
- 15.9.2.1.1 Sweden Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 15.9.2.2 Androgenic
- 15.9.2.2.1 Sweden Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 15.9.2.3 Others
- 15.9.2.3.1 Sweden Others Market Share and Revenue (USD Million) for 2018-2030
- 15.9.2.1 Anabolic
- 15.9.3 Sweden Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 15.9.3.1 Protein
- 15.9.3.1.1 Sweden Protein Market Share and Revenue (USD Million) for 2018-2030
- 15.9.3.2 Beta-alanine
- 15.9.3.2.1 Sweden Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 15.9.3.3 Creatine
- 15.9.3.3.1 Sweden Creatine Market Share and Revenue (USD Million) for 2018-2030
- 15.9.3.4 Caffeine
- 15.9.3.4.1 Sweden Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 15.9.3.5 Others
- 15.9.3.5.1 Sweden Others Market Share and Revenue (USD Million) for 2018-2030
- 15.9.3.1 Protein
- 15.9.4 Sweden Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 15.9.4.1 Offline
- 15.9.4.1.1 Sweden Offline Market Share and Revenue (USD Million) for 2018-2030
- 15.9.4.2 Online
- 15.9.4.2.1 Sweden Online Market Share and Revenue (USD Million) for 2018-2030
- 15.9.4.1 Offline
- 15.9.1 Sweden Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.10 Denmark Androgens and Anabolic Steroids Market Size (2018-2030)
- 15.10.1 Denmark Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.10.1.1 Oral
- 15.10.1.1.1 Denmark Oral Market Share and Revenue (USD Million) for 2018-2030
- 15.10.1.2 Injectables
- 15.10.1.2.1 Denmark Injectables Market Share and Revenue (USD Million) for 2018-2030
- 15.10.1.3 Topical
- 15.10.1.3.1 Denmark Topical Market Share and Revenue (USD Million) for 2018-2030
- 15.10.1.4 Others
- 15.10.1.4.1 Denmark Others Market Share and Revenue (USD Million) for 2018-2030
- 15.10.1.1 Oral
- 15.10.2 Denmark Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 15.10.2.1 Anabolic
- 15.10.2.1.1 Denmark Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 15.10.2.2 Androgenic
- 15.10.2.2.1 Denmark Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 15.10.2.3 Others
- 15.10.2.3.1 Denmark Others Market Share and Revenue (USD Million) for 2018-2030
- 15.10.2.1 Anabolic
- 15.10.3 Denmark Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 15.10.3.1 Protein
- 15.10.3.1.1 Denmark Protein Market Share and Revenue (USD Million) for 2018-2030
- 15.10.3.2 Beta-alanine
- 15.10.3.2.1 Denmark Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 15.10.3.3 Creatine
- 15.10.3.3.1 Denmark Creatine Market Share and Revenue (USD Million) for 2018-2030
- 15.10.3.4 Caffeine
- 15.10.3.4.1 Denmark Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 15.10.3.5 Others
- 15.10.3.5.1 Denmark Others Market Share and Revenue (USD Million) for 2018-2030
- 15.10.3.1 Protein
- 15.10.4 Denmark Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 15.10.4.1 Offline
- 15.10.4.1.1 Denmark Offline Market Share and Revenue (USD Million) for 2018-2030
- 15.10.4.2 Online
- 15.10.4.2.1 Denmark Online Market Share and Revenue (USD Million) for 2018-2030
- 15.10.4.1 Offline
- 15.10.1 Denmark Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.11 Netherlands Androgens and Anabolic Steroids Market Size (2018-2030)
- 15.11.1 Netherlands Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.11.1.1 Oral
- 15.11.1.1.1 Netherlands Oral Market Share and Revenue (USD Million) for 2018-2030
- 15.11.1.2 Injectables
- 15.11.1.2.1 Netherlands Injectables Market Share and Revenue (USD Million) for 2018-2030
- 15.11.1.3 Topical
- 15.11.1.3.1 Netherlands Topical Market Share and Revenue (USD Million) for 2018-2030
- 15.11.1.4 Others
- 15.11.1.4.1 Netherlands Others Market Share and Revenue (USD Million) for 2018-2030
- 15.11.1.1 Oral
- 15.11.2 Netherlands Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 15.11.2.1 Anabolic
- 15.11.2.1.1 Netherlands Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 15.11.2.2 Androgenic
- 15.11.2.2.1 Netherlands Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 15.11.2.3 Others
- 15.11.2.3.1 Netherlands Others Market Share and Revenue (USD Million) for 2018-2030
- 15.11.2.1 Anabolic
- 15.11.3 Netherlands Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 15.11.3.1 Protein
- 15.11.3.1.1 Netherlands Protein Market Share and Revenue (USD Million) for 2018-2030
- 15.11.3.2 Beta-alanine
- 15.11.3.2.1 Netherlands Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 15.11.3.3 Creatine
- 15.11.3.3.1 Netherlands Creatine Market Share and Revenue (USD Million) for 2018-2030
- 15.11.3.4 Caffeine
- 15.11.3.4.1 Netherlands Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 15.11.3.5 Others
- 15.11.3.5.1 Netherlands Others Market Share and Revenue (USD Million) for 2018-2030
- 15.11.3.1 Protein
- 15.11.4 Netherlands Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 15.11.4.1 Offline
- 15.11.4.1.1 Netherlands Offline Market Share and Revenue (USD Million) for 2018-2030
- 15.11.4.2 Online
- 15.11.4.2.1 Netherlands Online Market Share and Revenue (USD Million) for 2018-2030
- 15.11.4.1 Offline
- 15.11.1 Netherlands Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.12 Switzerland Androgens and Anabolic Steroids Market Size (2018-2030)
- 15.12.1 Switzerland Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.12.1.1 Oral
- 15.12.1.1.1 Switzerland Oral Market Share and Revenue (USD Million) for 2018-2030
- 15.12.1.2 Injectables
- 15.12.1.2.1 Switzerland Injectables Market Share and Revenue (USD Million) for 2018-2030
- 15.12.1.3 Topical
- 15.12.1.3.1 Switzerland Topical Market Share and Revenue (USD Million) for 2018-2030
- 15.12.1.4 Others
- 15.12.1.4.1 Switzerland Others Market Share and Revenue (USD Million) for 2018-2030
- 15.12.1.1 Oral
- 15.12.2 Switzerland Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 15.12.2.1 Anabolic
- 15.12.2.1.1 Switzerland Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 15.12.2.2 Androgenic
- 15.12.2.2.1 Switzerland Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 15.12.2.3 Others
- 15.12.2.3.1 Switzerland Others Market Share and Revenue (USD Million) for 2018-2030
- 15.12.2.1 Anabolic
- 15.12.3 Switzerland Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 15.12.3.1 Protein
- 15.12.3.1.1 Switzerland Protein Market Share and Revenue (USD Million) for 2018-2030
- 15.12.3.2 Beta-alanine
- 15.12.3.2.1 Switzerland Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 15.12.3.3 Creatine
- 15.12.3.3.1 Switzerland Creatine Market Share and Revenue (USD Million) for 2018-2030
- 15.12.3.4 Caffeine
- 15.12.3.4.1 Switzerland Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 15.12.3.5 Others
- 15.12.3.5.1 Switzerland Others Market Share and Revenue (USD Million) for 2018-2030
- 15.12.3.1 Protein
- 15.12.4 Switzerland Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 15.12.4.1 Offline
- 15.12.4.1.1 Switzerland Offline Market Share and Revenue (USD Million) for 2018-2030
- 15.12.4.2 Online
- 15.12.4.2.1 Switzerland Online Market Share and Revenue (USD Million) for 2018-2030
- 15.12.4.1 Offline
- 15.12.1 Switzerland Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.13 Belgium Androgens and Anabolic Steroids Market Size (2018-2030)
- 15.13.1 Belgium Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 15.13.1.1 Oral
- 15.13.1.1.1 Belgium Oral Market Share and Revenue (USD Million) for 2018-2030
- 15.13.1.2 Injectables
- 15.13.1.2.1 Belgium Injectables Market Share and Revenue (USD Million) for 2018-2030
- 15.13.1.3 Topical
- 15.13.1.3.1 Belgium Topical Market Share and Revenue (USD Million) for 2018-2030
- 15.13.1.4 Others
- 15.13.1.4.1 Belgium Others Market Share and Revenue (USD Million) for 2018-2030
- 15.13.1.1 Oral
- 15.13.2 Belgium Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 15.13.2.1 Anabolic
- 15.13.2.1.1 Belgium Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 15.13.2.2 Androgenic
- 15.13.2.2.1 Belgium Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 15.13.2.3 Others
- 15.13.2.3.1 Belgium Others Market Share and Revenue (USD Million) for 2018-2030
- 15.13.2.1 Anabolic
- 15.13.3 Belgium Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 15.13.3.1 Protein
- 15.13.3.1.1 Belgium Protein Market Share and Revenue (USD Million) for 2018-2030
- 15.13.3.2 Beta-alanine
- 15.13.3.2.1 Belgium Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 15.13.3.3 Creatine
- 15.13.3.3.1 Belgium Creatine Market Share and Revenue (USD Million) for 2018-2030
- 15.13.3.4 Caffeine
- 15.13.3.4.1 Belgium Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 15.13.3.5 Others
- 15.13.3.5.1 Belgium Others Market Share and Revenue (USD Million) for 2018-2030
- 15.13.3.1 Protein
- 15.13.4 Belgium Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 15.13.4.1 Offline
- 15.13.4.1.1 Belgium Offline Market Share and Revenue (USD Million) for 2018-2030
- 15.13.4.2 Online
- 15.13.4.2.1 Belgium Online Market Share and Revenue (USD Million) for 2018-2030
- 15.13.4.1 Offline
- 15.13.1 Belgium Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.1 Asia Pacific
- 16.1.1 Asia Pacific Androgens and Anabolic Steroids Market Trends and Analysis
- 16.1.2 Asia Pacific Androgens and Anabolic Steroids Market by Country, 2018-2030
- 16.1.3 Asia Pacific Androgens and Anabolic Steroids Market Attractiveness Analysis by Country
- 16.2 Asia Pacific Androgens and Anabolic Steroids Market Size (2018-2030)
- 16.2.1 Asia Pacific Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.2.1.1 Oral
- 16.2.1.1.1 Asia Pacific Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.2 Injectables
- 16.2.1.2.1 Asia Pacific Injectables Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.3 Topical
- 16.2.1.3.1 Asia Pacific Topical Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.4 Others
- 16.2.1.4.1 Asia Pacific Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.1 Oral
- 16.2.2 Asia Pacific Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 16.2.2.1 Anabolic
- 16.2.2.1.1 Asia Pacific Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.2 Androgenic
- 16.2.2.2.1 Asia Pacific Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.3 Others
- 16.2.2.3.1 Asia Pacific Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.1 Anabolic
- 16.2.3 Asia Pacific Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 16.2.3.1 Protein
- 16.2.3.1.1 Asia Pacific Protein Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.2 Beta-alanine
- 16.2.3.2.1 Asia Pacific Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.3 Creatine
- 16.2.3.3.1 Asia Pacific Creatine Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.4 Caffeine
- 16.2.3.4.1 Asia Pacific Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.5 Others
- 16.2.3.5.1 Asia Pacific Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.1 Protein
- 16.2.4 Asia Pacific Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 16.2.4.1 Offline
- 16.2.4.1.1 Asia Pacific Offline Market Share and Revenue (USD Million) for 2018-2030
- 16.2.4.2 Online
- 16.2.4.2.1 Asia Pacific Online Market Share and Revenue (USD Million) for 2018-2030
- 16.2.4.1 Offline
- 16.2.1 Asia Pacific Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.3 China Androgens and Anabolic Steroids Market Size (2018-2030)
- 16.3.1 China Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.3.1.1 Oral
- 16.3.1.1.1 China Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.2 Injectables
- 16.3.1.2.1 China Injectables Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.3 Topical
- 16.3.1.3.1 China Topical Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.4 Others
- 16.3.1.4.1 China Others Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.1 Oral
- 16.3.2 China Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 16.3.2.1 Anabolic
- 16.3.2.1.1 China Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 16.3.2.2 Androgenic
- 16.3.2.2.1 China Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 16.3.2.3 Others
- 16.3.2.3.1 China Others Market Share and Revenue (USD Million) for 2018-2030
- 16.3.2.1 Anabolic
- 16.3.3 China Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 16.3.3.1 Protein
- 16.3.3.1.1 China Protein Market Share and Revenue (USD Million) for 2018-2030
- 16.3.3.2 Beta-alanine
- 16.3.3.2.1 China Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 16.3.3.3 Creatine
- 16.3.3.3.1 China Creatine Market Share and Revenue (USD Million) for 2018-2030
- 16.3.3.4 Caffeine
- 16.3.3.4.1 China Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 16.3.3.5 Others
- 16.3.3.5.1 China Others Market Share and Revenue (USD Million) for 2018-2030
- 16.3.3.1 Protein
- 16.3.4 China Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 16.3.4.1 Offline
- 16.3.4.1.1 China Offline Market Share and Revenue (USD Million) for 2018-2030
- 16.3.4.2 Online
- 16.3.4.2.1 China Online Market Share and Revenue (USD Million) for 2018-2030
- 16.3.4.1 Offline
- 16.3.1 China Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.4 Japan Androgens and Anabolic Steroids Market Size (2018-2030)
- 16.4.1 Japan Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.4.1.1 Oral
- 16.4.1.1.1 Japan Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.2 Injectables
- 16.4.1.2.1 Japan Injectables Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.3 Topical
- 16.4.1.3.1 Japan Topical Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.4 Others
- 16.4.1.4.1 Japan Others Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.1 Oral
- 16.4.2 Japan Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 16.4.2.1 Anabolic
- 16.4.2.1.1 Japan Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 16.4.2.2 Androgenic
- 16.4.2.2.1 Japan Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 16.4.2.3 Others
- 16.4.2.3.1 Japan Others Market Share and Revenue (USD Million) for 2018-2030
- 16.4.2.1 Anabolic
- 16.4.3 Japan Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 16.4.3.1 Protein
- 16.4.3.1.1 Japan Protein Market Share and Revenue (USD Million) for 2018-2030
- 16.4.3.2 Beta-alanine
- 16.4.3.2.1 Japan Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 16.4.3.3 Creatine
- 16.4.3.3.1 Japan Creatine Market Share and Revenue (USD Million) for 2018-2030
- 16.4.3.4 Caffeine
- 16.4.3.4.1 Japan Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 16.4.3.5 Others
- 16.4.3.5.1 Japan Others Market Share and Revenue (USD Million) for 2018-2030
- 16.4.3.1 Protein
- 16.4.4 Japan Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 16.4.4.1 Offline
- 16.4.4.1.1 Japan Offline Market Share and Revenue (USD Million) for 2018-2030
- 16.4.4.2 Online
- 16.4.4.2.1 Japan Online Market Share and Revenue (USD Million) for 2018-2030
- 16.4.4.1 Offline
- 16.4.1 Japan Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.5 Korea Androgens and Anabolic Steroids Market Size (2018-2030)
- 16.5.1 Korea Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.5.1.1 Oral
- 16.5.1.1.1 Korea Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.2 Injectables
- 16.5.1.2.1 Korea Injectables Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.3 Topical
- 16.5.1.3.1 Korea Topical Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.4 Others
- 16.5.1.4.1 Korea Others Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.1 Oral
- 16.5.2 Korea Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 16.5.2.1 Anabolic
- 16.5.2.1.1 Korea Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 16.5.2.2 Androgenic
- 16.5.2.2.1 Korea Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 16.5.2.3 Others
- 16.5.2.3.1 Korea Others Market Share and Revenue (USD Million) for 2018-2030
- 16.5.2.1 Anabolic
- 16.5.3 Korea Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 16.5.3.1 Protein
- 16.5.3.1.1 Korea Protein Market Share and Revenue (USD Million) for 2018-2030
- 16.5.3.2 Beta-alanine
- 16.5.3.2.1 Korea Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 16.5.3.3 Creatine
- 16.5.3.3.1 Korea Creatine Market Share and Revenue (USD Million) for 2018-2030
- 16.5.3.4 Caffeine
- 16.5.3.4.1 Korea Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 16.5.3.5 Others
- 16.5.3.5.1 Korea Others Market Share and Revenue (USD Million) for 2018-2030
- 16.5.3.1 Protein
- 16.5.4 Korea Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 16.5.4.1 Offline
- 16.5.4.1.1 Korea Offline Market Share and Revenue (USD Million) for 2018-2030
- 16.5.4.2 Online
- 16.5.4.2.1 Korea Online Market Share and Revenue (USD Million) for 2018-2030
- 16.5.4.1 Offline
- 16.5.1 Korea Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.6 India Androgens and Anabolic Steroids Market Size (2018-2030)
- 16.6.1 India Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.6.1.1 Oral
- 16.6.1.1.1 India Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.2 Injectables
- 16.6.1.2.1 India Injectables Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.3 Topical
- 16.6.1.3.1 India Topical Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.4 Others
- 16.6.1.4.1 India Others Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.1 Oral
- 16.6.2 India Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 16.6.2.1 Anabolic
- 16.6.2.1.1 India Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 16.6.2.2 Androgenic
- 16.6.2.2.1 India Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 16.6.2.3 Others
- 16.6.2.3.1 India Others Market Share and Revenue (USD Million) for 2018-2030
- 16.6.2.1 Anabolic
- 16.6.3 India Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 16.6.3.1 Protein
- 16.6.3.1.1 India Protein Market Share and Revenue (USD Million) for 2018-2030
- 16.6.3.2 Beta-alanine
- 16.6.3.2.1 India Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 16.6.3.3 Creatine
- 16.6.3.3.1 India Creatine Market Share and Revenue (USD Million) for 2018-2030
- 16.6.3.4 Caffeine
- 16.6.3.4.1 India Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 16.6.3.5 Others
- 16.6.3.5.1 India Others Market Share and Revenue (USD Million) for 2018-2030
- 16.6.3.1 Protein
- 16.6.4 India Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 16.6.4.1 Offline
- 16.6.4.1.1 India Offline Market Share and Revenue (USD Million) for 2018-2030
- 16.6.4.2 Online
- 16.6.4.2.1 India Online Market Share and Revenue (USD Million) for 2018-2030
- 16.6.4.1 Offline
- 16.6.1 India Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.7 Australia Androgens and Anabolic Steroids Market Size (2018-2030)
- 16.7.1 Australia Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.7.1.1 Oral
- 16.7.1.1.1 Australia Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.2 Injectables
- 16.7.1.2.1 Australia Injectables Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.3 Topical
- 16.7.1.3.1 Australia Topical Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.4 Others
- 16.7.1.4.1 Australia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.1 Oral
- 16.7.2 Australia Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 16.7.2.1 Anabolic
- 16.7.2.1.1 Australia Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 16.7.2.2 Androgenic
- 16.7.2.2.1 Australia Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 16.7.2.3 Others
- 16.7.2.3.1 Australia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.7.2.1 Anabolic
- 16.7.3 Australia Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 16.7.3.1 Protein
- 16.7.3.1.1 Australia Protein Market Share and Revenue (USD Million) for 2018-2030
- 16.7.3.2 Beta-alanine
- 16.7.3.2.1 Australia Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 16.7.3.3 Creatine
- 16.7.3.3.1 Australia Creatine Market Share and Revenue (USD Million) for 2018-2030
- 16.7.3.4 Caffeine
- 16.7.3.4.1 Australia Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 16.7.3.5 Others
- 16.7.3.5.1 Australia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.7.3.1 Protein
- 16.7.4 Australia Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 16.7.4.1 Offline
- 16.7.4.1.1 Australia Offline Market Share and Revenue (USD Million) for 2018-2030
- 16.7.4.2 Online
- 16.7.4.2.1 Australia Online Market Share and Revenue (USD Million) for 2018-2030
- 16.7.4.1 Offline
- 16.7.1 Australia Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.8 Philippines Androgens and Anabolic Steroids Market Size (2018-2030)
- 16.8.1 Philippines Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.8.1.1 Oral
- 16.8.1.1.1 Philippines Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.2 Injectables
- 16.8.1.2.1 Philippines Injectables Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.3 Topical
- 16.8.1.3.1 Philippines Topical Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.4 Others
- 16.8.1.4.1 Philippines Others Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.1 Oral
- 16.8.2 Philippines Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 16.8.2.1 Anabolic
- 16.8.2.1.1 Philippines Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 16.8.2.2 Androgenic
- 16.8.2.2.1 Philippines Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 16.8.2.3 Others
- 16.8.2.3.1 Philippines Others Market Share and Revenue (USD Million) for 2018-2030
- 16.8.2.1 Anabolic
- 16.8.3 Philippines Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 16.8.3.1 Protein
- 16.8.3.1.1 Philippines Protein Market Share and Revenue (USD Million) for 2018-2030
- 16.8.3.2 Beta-alanine
- 16.8.3.2.1 Philippines Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 16.8.3.3 Creatine
- 16.8.3.3.1 Philippines Creatine Market Share and Revenue (USD Million) for 2018-2030
- 16.8.3.4 Caffeine
- 16.8.3.4.1 Philippines Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 16.8.3.5 Others
- 16.8.3.5.1 Philippines Others Market Share and Revenue (USD Million) for 2018-2030
- 16.8.3.1 Protein
- 16.8.4 Philippines Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 16.8.4.1 Offline
- 16.8.4.1.1 Philippines Offline Market Share and Revenue (USD Million) for 2018-2030
- 16.8.4.2 Online
- 16.8.4.2.1 Philippines Online Market Share and Revenue (USD Million) for 2018-2030
- 16.8.4.1 Offline
- 16.8.1 Philippines Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.9 Singapore Androgens and Anabolic Steroids Market Size (2018-2030)
- 16.9.1 Singapore Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.9.1.1 Oral
- 16.9.1.1.1 Singapore Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.2 Injectables
- 16.9.1.2.1 Singapore Injectables Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.3 Topical
- 16.9.1.3.1 Singapore Topical Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.4 Others
- 16.9.1.4.1 Singapore Others Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.1 Oral
- 16.9.2 Singapore Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 16.9.2.1 Anabolic
- 16.9.2.1.1 Singapore Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 16.9.2.2 Androgenic
- 16.9.2.2.1 Singapore Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 16.9.2.3 Others
- 16.9.2.3.1 Singapore Others Market Share and Revenue (USD Million) for 2018-2030
- 16.9.2.1 Anabolic
- 16.9.3 Singapore Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 16.9.3.1 Protein
- 16.9.3.1.1 Singapore Protein Market Share and Revenue (USD Million) for 2018-2030
- 16.9.3.2 Beta-alanine
- 16.9.3.2.1 Singapore Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 16.9.3.3 Creatine
- 16.9.3.3.1 Singapore Creatine Market Share and Revenue (USD Million) for 2018-2030
- 16.9.3.4 Caffeine
- 16.9.3.4.1 Singapore Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 16.9.3.5 Others
- 16.9.3.5.1 Singapore Others Market Share and Revenue (USD Million) for 2018-2030
- 16.9.3.1 Protein
- 16.9.4 Singapore Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 16.9.4.1 Offline
- 16.9.4.1.1 Singapore Offline Market Share and Revenue (USD Million) for 2018-2030
- 16.9.4.2 Online
- 16.9.4.2.1 Singapore Online Market Share and Revenue (USD Million) for 2018-2030
- 16.9.4.1 Offline
- 16.9.1 Singapore Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.10 Malaysia Androgens and Anabolic Steroids Market Size (2018-2030)
- 16.10.1 Malaysia Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.10.1.1 Oral
- 16.10.1.1.1 Malaysia Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.2 Injectables
- 16.10.1.2.1 Malaysia Injectables Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.3 Topical
- 16.10.1.3.1 Malaysia Topical Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.4 Others
- 16.10.1.4.1 Malaysia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.1 Oral
- 16.10.2 Malaysia Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 16.10.2.1 Anabolic
- 16.10.2.1.1 Malaysia Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 16.10.2.2 Androgenic
- 16.10.2.2.1 Malaysia Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 16.10.2.3 Others
- 16.10.2.3.1 Malaysia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.10.2.1 Anabolic
- 16.10.3 Malaysia Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 16.10.3.1 Protein
- 16.10.3.1.1 Malaysia Protein Market Share and Revenue (USD Million) for 2018-2030
- 16.10.3.2 Beta-alanine
- 16.10.3.2.1 Malaysia Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 16.10.3.3 Creatine
- 16.10.3.3.1 Malaysia Creatine Market Share and Revenue (USD Million) for 2018-2030
- 16.10.3.4 Caffeine
- 16.10.3.4.1 Malaysia Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 16.10.3.5 Others
- 16.10.3.5.1 Malaysia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.10.3.1 Protein
- 16.10.4 Malaysia Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 16.10.4.1 Offline
- 16.10.4.1.1 Malaysia Offline Market Share and Revenue (USD Million) for 2018-2030
- 16.10.4.2 Online
- 16.10.4.2.1 Malaysia Online Market Share and Revenue (USD Million) for 2018-2030
- 16.10.4.1 Offline
- 16.10.1 Malaysia Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.11 Thailand Androgens and Anabolic Steroids Market Size (2018-2030)
- 16.11.1 Thailand Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.11.1.1 Oral
- 16.11.1.1.1 Thailand Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.2 Injectables
- 16.11.1.2.1 Thailand Injectables Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.3 Topical
- 16.11.1.3.1 Thailand Topical Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.4 Others
- 16.11.1.4.1 Thailand Others Market Share and Revenue (USD Million) for 2018-2030
- 16.11.1.1 Oral
- 16.11.2 Thailand Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 16.11.2.1 Anabolic
- 16.11.2.1.1 Thailand Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 16.11.2.2 Androgenic
- 16.11.2.2.1 Thailand Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 16.11.2.3 Others
- 16.11.2.3.1 Thailand Others Market Share and Revenue (USD Million) for 2018-2030
- 16.11.2.1 Anabolic
- 16.11.3 Thailand Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 16.11.3.1 Protein
- 16.11.3.1.1 Thailand Protein Market Share and Revenue (USD Million) for 2018-2030
- 16.11.3.2 Beta-alanine
- 16.11.3.2.1 Thailand Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 16.11.3.3 Creatine
- 16.11.3.3.1 Thailand Creatine Market Share and Revenue (USD Million) for 2018-2030
- 16.11.3.4 Caffeine
- 16.11.3.4.1 Thailand Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 16.11.3.5 Others
- 16.11.3.5.1 Thailand Others Market Share and Revenue (USD Million) for 2018-2030
- 16.11.3.1 Protein
- 16.11.4 Thailand Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 16.11.4.1 Offline
- 16.11.4.1.1 Thailand Offline Market Share and Revenue (USD Million) for 2018-2030
- 16.11.4.2 Online
- 16.11.4.2.1 Thailand Online Market Share and Revenue (USD Million) for 2018-2030
- 16.11.4.1 Offline
- 16.11.1 Thailand Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.12 Indonesia Androgens and Anabolic Steroids Market Size (2018-2030)
- 16.12.1 Indonesia Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.12.1.1 Oral
- 16.12.1.1.1 Indonesia Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.2 Injectables
- 16.12.1.2.1 Indonesia Injectables Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.3 Topical
- 16.12.1.3.1 Indonesia Topical Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.4 Others
- 16.12.1.4.1 Indonesia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.12.1.1 Oral
- 16.12.2 Indonesia Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 16.12.2.1 Anabolic
- 16.12.2.1.1 Indonesia Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 16.12.2.2 Androgenic
- 16.12.2.2.1 Indonesia Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 16.12.2.3 Others
- 16.12.2.3.1 Indonesia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.12.2.1 Anabolic
- 16.12.3 Indonesia Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 16.12.3.1 Protein
- 16.12.3.1.1 Indonesia Protein Market Share and Revenue (USD Million) for 2018-2030
- 16.12.3.2 Beta-alanine
- 16.12.3.2.1 Indonesia Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 16.12.3.3 Creatine
- 16.12.3.3.1 Indonesia Creatine Market Share and Revenue (USD Million) for 2018-2030
- 16.12.3.4 Caffeine
- 16.12.3.4.1 Indonesia Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 16.12.3.5 Others
- 16.12.3.5.1 Indonesia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.12.3.1 Protein
- 16.12.4 Indonesia Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 16.12.4.1 Offline
- 16.12.4.1.1 Indonesia Offline Market Share and Revenue (USD Million) for 2018-2030
- 16.12.4.2 Online
- 16.12.4.2.1 Indonesia Online Market Share and Revenue (USD Million) for 2018-2030
- 16.12.4.1 Offline
- 16.12.1 Indonesia Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.13 Rest of APAC Androgens and Anabolic Steroids Market Size (2018-2030)
- 16.13.1 Rest of APAC Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 16.13.1.1 Oral
- 16.13.1.1.1 Rest of APAC Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.2 Injectables
- 16.13.1.2.1 Rest of APAC Injectables Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.3 Topical
- 16.13.1.3.1 Rest of APAC Topical Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.4 Others
- 16.13.1.4.1 Rest of APAC Others Market Share and Revenue (USD Million) for 2018-2030
- 16.13.1.1 Oral
- 16.13.2 Rest of APAC Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 16.13.2.1 Anabolic
- 16.13.2.1.1 Rest of APAC Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 16.13.2.2 Androgenic
- 16.13.2.2.1 Rest of APAC Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 16.13.2.3 Others
- 16.13.2.3.1 Rest of APAC Others Market Share and Revenue (USD Million) for 2018-2030
- 16.13.2.1 Anabolic
- 16.13.3 Rest of APAC Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 16.13.3.1 Protein
- 16.13.3.1.1 Rest of APAC Protein Market Share and Revenue (USD Million) for 2018-2030
- 16.13.3.2 Beta-alanine
- 16.13.3.2.1 Rest of APAC Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 16.13.3.3 Creatine
- 16.13.3.3.1 Rest of APAC Creatine Market Share and Revenue (USD Million) for 2018-2030
- 16.13.3.4 Caffeine
- 16.13.3.4.1 Rest of APAC Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 16.13.3.5 Others
- 16.13.3.5.1 Rest of APAC Others Market Share and Revenue (USD Million) for 2018-2030
- 16.13.3.1 Protein
- 16.13.4 Rest of APAC Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 16.13.4.1 Offline
- 16.13.4.1.1 Rest of APAC Offline Market Share and Revenue (USD Million) for 2018-2030
- 16.13.4.2 Online
- 16.13.4.2.1 Rest of APAC Online Market Share and Revenue (USD Million) for 2018-2030
- 16.13.4.1 Offline
- 16.13.1 Rest of APAC Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.1 Latin America
- 17.1.1 Latin America Androgens and Anabolic Steroids Market Trends and Analysis
- 17.1.2 Latin America Androgens and Anabolic Steroids Market by Country, 2018-2030
- 17.1.3 Latin America Androgens and Anabolic Steroids Market Attractiveness Analysis by Country
- 17.2 Latin America Androgens and Anabolic Steroids Market Size (2018-2030)
- 17.2.1 Latin America Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.2.1.1 Oral
- 17.2.1.1.1 Latin America Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Injectables
- 17.2.1.2.1 Latin America Injectables Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.3 Topical
- 17.2.1.3.1 Latin America Topical Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.4 Others
- 17.2.1.4.1 Latin America Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Oral
- 17.2.2 Latin America Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 17.2.2.1 Anabolic
- 17.2.2.1.1 Latin America Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Androgenic
- 17.2.2.2.1 Latin America Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.3 Others
- 17.2.2.3.1 Latin America Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Anabolic
- 17.2.3 Latin America Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 17.2.3.1 Protein
- 17.2.3.1.1 Latin America Protein Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Beta-alanine
- 17.2.3.2.1 Latin America Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.3 Creatine
- 17.2.3.3.1 Latin America Creatine Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.4 Caffeine
- 17.2.3.4.1 Latin America Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.5 Others
- 17.2.3.5.1 Latin America Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 Protein
- 17.2.4 Latin America Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 17.2.4.1 Offline
- 17.2.4.1.1 Latin America Offline Market Share and Revenue (USD Million) for 2018-2030
- 17.2.4.2 Online
- 17.2.4.2.1 Latin America Online Market Share and Revenue (USD Million) for 2018-2030
- 17.2.4.1 Offline
- 17.2.1 Latin America Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.3 Brazil Androgens and Anabolic Steroids Market Size (2018-2030)
- 17.3.1 Brazil Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.3.1.1 Oral
- 17.3.1.1.1 Brazil Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.2 Injectables
- 17.3.1.2.1 Brazil Injectables Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.3 Topical
- 17.3.1.3.1 Brazil Topical Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.4 Others
- 17.3.1.4.1 Brazil Others Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.1 Oral
- 17.3.2 Brazil Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 17.3.2.1 Anabolic
- 17.3.2.1.1 Brazil Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 17.3.2.2 Androgenic
- 17.3.2.2.1 Brazil Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 17.3.2.3 Others
- 17.3.2.3.1 Brazil Others Market Share and Revenue (USD Million) for 2018-2030
- 17.3.2.1 Anabolic
- 17.3.3 Brazil Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 17.3.3.1 Protein
- 17.3.3.1.1 Brazil Protein Market Share and Revenue (USD Million) for 2018-2030
- 17.3.3.2 Beta-alanine
- 17.3.3.2.1 Brazil Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 17.3.3.3 Creatine
- 17.3.3.3.1 Brazil Creatine Market Share and Revenue (USD Million) for 2018-2030
- 17.3.3.4 Caffeine
- 17.3.3.4.1 Brazil Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 17.3.3.5 Others
- 17.3.3.5.1 Brazil Others Market Share and Revenue (USD Million) for 2018-2030
- 17.3.3.1 Protein
- 17.3.4 Brazil Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 17.3.4.1 Offline
- 17.3.4.1.1 Brazil Offline Market Share and Revenue (USD Million) for 2018-2030
- 17.3.4.2 Online
- 17.3.4.2.1 Brazil Online Market Share and Revenue (USD Million) for 2018-2030
- 17.3.4.1 Offline
- 17.3.1 Brazil Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.4 Argentina Androgens and Anabolic Steroids Market Size (2018-2030)
- 17.4.1 Argentina Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.4.1.1 Oral
- 17.4.1.1.1 Argentina Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.2 Injectables
- 17.4.1.2.1 Argentina Injectables Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.3 Topical
- 17.4.1.3.1 Argentina Topical Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.4 Others
- 17.4.1.4.1 Argentina Others Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.1 Oral
- 17.4.2 Argentina Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 17.4.2.1 Anabolic
- 17.4.2.1.1 Argentina Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 17.4.2.2 Androgenic
- 17.4.2.2.1 Argentina Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 17.4.2.3 Others
- 17.4.2.3.1 Argentina Others Market Share and Revenue (USD Million) for 2018-2030
- 17.4.2.1 Anabolic
- 17.4.3 Argentina Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 17.4.3.1 Protein
- 17.4.3.1.1 Argentina Protein Market Share and Revenue (USD Million) for 2018-2030
- 17.4.3.2 Beta-alanine
- 17.4.3.2.1 Argentina Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 17.4.3.3 Creatine
- 17.4.3.3.1 Argentina Creatine Market Share and Revenue (USD Million) for 2018-2030
- 17.4.3.4 Caffeine
- 17.4.3.4.1 Argentina Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 17.4.3.5 Others
- 17.4.3.5.1 Argentina Others Market Share and Revenue (USD Million) for 2018-2030
- 17.4.3.1 Protein
- 17.4.4 Argentina Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 17.4.4.1 Offline
- 17.4.4.1.1 Argentina Offline Market Share and Revenue (USD Million) for 2018-2030
- 17.4.4.2 Online
- 17.4.4.2.1 Argentina Online Market Share and Revenue (USD Million) for 2018-2030
- 17.4.4.1 Offline
- 17.4.1 Argentina Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.5 Colombia Androgens and Anabolic Steroids Market Size (2018-2030)
- 17.5.1 Colombia Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.5.1.1 Oral
- 17.5.1.1.1 Colombia Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.2 Injectables
- 17.5.1.2.1 Colombia Injectables Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.3 Topical
- 17.5.1.3.1 Colombia Topical Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.4 Others
- 17.5.1.4.1 Colombia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.1 Oral
- 17.5.2 Colombia Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 17.5.2.1 Anabolic
- 17.5.2.1.1 Colombia Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 17.5.2.2 Androgenic
- 17.5.2.2.1 Colombia Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 17.5.2.3 Others
- 17.5.2.3.1 Colombia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.5.2.1 Anabolic
- 17.5.3 Colombia Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 17.5.3.1 Protein
- 17.5.3.1.1 Colombia Protein Market Share and Revenue (USD Million) for 2018-2030
- 17.5.3.2 Beta-alanine
- 17.5.3.2.1 Colombia Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 17.5.3.3 Creatine
- 17.5.3.3.1 Colombia Creatine Market Share and Revenue (USD Million) for 2018-2030
- 17.5.3.4 Caffeine
- 17.5.3.4.1 Colombia Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 17.5.3.5 Others
- 17.5.3.5.1 Colombia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.5.3.1 Protein
- 17.5.4 Colombia Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 17.5.4.1 Offline
- 17.5.4.1.1 Colombia Offline Market Share and Revenue (USD Million) for 2018-2030
- 17.5.4.2 Online
- 17.5.4.2.1 Colombia Online Market Share and Revenue (USD Million) for 2018-2030
- 17.5.4.1 Offline
- 17.5.1 Colombia Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.6 Peru Androgens and Anabolic Steroids Market Size (2018-2030)
- 17.6.1 Peru Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.6.1.1 Oral
- 17.6.1.1.1 Peru Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.2 Injectables
- 17.6.1.2.1 Peru Injectables Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.3 Topical
- 17.6.1.3.1 Peru Topical Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.4 Others
- 17.6.1.4.1 Peru Others Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.1 Oral
- 17.6.2 Peru Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 17.6.2.1 Anabolic
- 17.6.2.1.1 Peru Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 17.6.2.2 Androgenic
- 17.6.2.2.1 Peru Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 17.6.2.3 Others
- 17.6.2.3.1 Peru Others Market Share and Revenue (USD Million) for 2018-2030
- 17.6.2.1 Anabolic
- 17.6.3 Peru Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 17.6.3.1 Protein
- 17.6.3.1.1 Peru Protein Market Share and Revenue (USD Million) for 2018-2030
- 17.6.3.2 Beta-alanine
- 17.6.3.2.1 Peru Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 17.6.3.3 Creatine
- 17.6.3.3.1 Peru Creatine Market Share and Revenue (USD Million) for 2018-2030
- 17.6.3.4 Caffeine
- 17.6.3.4.1 Peru Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 17.6.3.5 Others
- 17.6.3.5.1 Peru Others Market Share and Revenue (USD Million) for 2018-2030
- 17.6.3.1 Protein
- 17.6.4 Peru Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 17.6.4.1 Offline
- 17.6.4.1.1 Peru Offline Market Share and Revenue (USD Million) for 2018-2030
- 17.6.4.2 Online
- 17.6.4.2.1 Peru Online Market Share and Revenue (USD Million) for 2018-2030
- 17.6.4.1 Offline
- 17.6.1 Peru Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.7 Chile Androgens and Anabolic Steroids Market Size (2018-2030)
- 17.7.1 Chile Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.7.1.1 Oral
- 17.7.1.1.1 Chile Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.2 Injectables
- 17.7.1.2.1 Chile Injectables Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.3 Topical
- 17.7.1.3.1 Chile Topical Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.4 Others
- 17.7.1.4.1 Chile Others Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.1 Oral
- 17.7.2 Chile Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 17.7.2.1 Anabolic
- 17.7.2.1.1 Chile Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 17.7.2.2 Androgenic
- 17.7.2.2.1 Chile Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 17.7.2.3 Others
- 17.7.2.3.1 Chile Others Market Share and Revenue (USD Million) for 2018-2030
- 17.7.2.1 Anabolic
- 17.7.3 Chile Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 17.7.3.1 Protein
- 17.7.3.1.1 Chile Protein Market Share and Revenue (USD Million) for 2018-2030
- 17.7.3.2 Beta-alanine
- 17.7.3.2.1 Chile Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 17.7.3.3 Creatine
- 17.7.3.3.1 Chile Creatine Market Share and Revenue (USD Million) for 2018-2030
- 17.7.3.4 Caffeine
- 17.7.3.4.1 Chile Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 17.7.3.5 Others
- 17.7.3.5.1 Chile Others Market Share and Revenue (USD Million) for 2018-2030
- 17.7.3.1 Protein
- 17.7.4 Chile Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 17.7.4.1 Offline
- 17.7.4.1.1 Chile Offline Market Share and Revenue (USD Million) for 2018-2030
- 17.7.4.2 Online
- 17.7.4.2.1 Chile Online Market Share and Revenue (USD Million) for 2018-2030
- 17.7.4.1 Offline
- 17.7.1 Chile Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.8 Rest of South America Androgens and Anabolic Steroids Market Size (2018-2030)
- 17.8.1 Rest of South America Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 17.8.1.1 Oral
- 17.8.1.1.1 Rest of South America Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.2 Injectables
- 17.8.1.2.1 Rest of South America Injectables Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.3 Topical
- 17.8.1.3.1 Rest of South America Topical Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.4 Others
- 17.8.1.4.1 Rest of South America Others Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.1 Oral
- 17.8.2 Rest of South America Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 17.8.2.1 Anabolic
- 17.8.2.1.1 Rest of South America Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 17.8.2.2 Androgenic
- 17.8.2.2.1 Rest of South America Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 17.8.2.3 Others
- 17.8.2.3.1 Rest of South America Others Market Share and Revenue (USD Million) for 2018-2030
- 17.8.2.1 Anabolic
- 17.8.3 Rest of South America Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 17.8.3.1 Protein
- 17.8.3.1.1 Rest of South America Protein Market Share and Revenue (USD Million) for 2018-2030
- 17.8.3.2 Beta-alanine
- 17.8.3.2.1 Rest of South America Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 17.8.3.3 Creatine
- 17.8.3.3.1 Rest of South America Creatine Market Share and Revenue (USD Million) for 2018-2030
- 17.8.3.4 Caffeine
- 17.8.3.4.1 Rest of South America Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 17.8.3.5 Others
- 17.8.3.5.1 Rest of South America Others Market Share and Revenue (USD Million) for 2018-2030
- 17.8.3.1 Protein
- 17.8.4 Rest of South America Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 17.8.4.1 Offline
- 17.8.4.1.1 Rest of South America Offline Market Share and Revenue (USD Million) for 2018-2030
- 17.8.4.2 Online
- 17.8.4.2.1 Rest of South America Online Market Share and Revenue (USD Million) for 2018-2030
- 17.8.4.1 Offline
- 17.8.1 Rest of South America Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.1 Middle East and Africa
- 18.1.1 Middle East and Africa Androgens and Anabolic Steroids Market Trends and Analysis
- 18.1.2 Middle East and Africa Androgens and Anabolic Steroids Market by Country, 2018-2030
- 18.1.3 Middle East and Africa Androgens and Anabolic Steroids Market Attractiveness Analysis by Country
- 18.2 Middle East and Africa Androgens and Anabolic Steroids Market Size (2018-2030)
- 18.2.1 Middle East and Africa Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.2.1.1 Oral
- 18.2.1.1.1 Middle East and Africa Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.2 Injectables
- 18.2.1.2.1 Middle East and Africa Injectables Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.3 Topical
- 18.2.1.3.1 Middle East and Africa Topical Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.4 Others
- 18.2.1.4.1 Middle East and Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.1 Oral
- 18.2.2 Middle East and Africa Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 18.2.2.1 Anabolic
- 18.2.2.1.1 Middle East and Africa Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 18.2.2.2 Androgenic
- 18.2.2.2.1 Middle East and Africa Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 18.2.2.3 Others
- 18.2.2.3.1 Middle East and Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 18.2.2.1 Anabolic
- 18.2.3 Middle East and Africa Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 18.2.3.1 Protein
- 18.2.3.1.1 Middle East and Africa Protein Market Share and Revenue (USD Million) for 2018-2030
- 18.2.3.2 Beta-alanine
- 18.2.3.2.1 Middle East and Africa Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 18.2.3.3 Creatine
- 18.2.3.3.1 Middle East and Africa Creatine Market Share and Revenue (USD Million) for 2018-2030
- 18.2.3.4 Caffeine
- 18.2.3.4.1 Middle East and Africa Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 18.2.3.5 Others
- 18.2.3.5.1 Middle East and Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 18.2.3.1 Protein
- 18.2.4 Middle East and Africa Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 18.2.4.1 Offline
- 18.2.4.1.1 Middle East and Africa Offline Market Share and Revenue (USD Million) for 2018-2030
- 18.2.4.2 Online
- 18.2.4.2.1 Middle East and Africa Online Market Share and Revenue (USD Million) for 2018-2030
- 18.2.4.1 Offline
- 18.2.1 Middle East and Africa Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.3 Saudi Arabia Androgens and Anabolic Steroids Market Size (2018-2030)
- 18.3.1 Saudi Arabia Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.3.1.1 Oral
- 18.3.1.1.1 Saudi Arabia Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.2 Injectables
- 18.3.1.2.1 Saudi Arabia Injectables Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.3 Topical
- 18.3.1.3.1 Saudi Arabia Topical Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.4 Others
- 18.3.1.4.1 Saudi Arabia Others Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.1 Oral
- 18.3.2 Saudi Arabia Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 18.3.2.1 Anabolic
- 18.3.2.1.1 Saudi Arabia Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 18.3.2.2 Androgenic
- 18.3.2.2.1 Saudi Arabia Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 18.3.2.3 Others
- 18.3.2.3.1 Saudi Arabia Others Market Share and Revenue (USD Million) for 2018-2030
- 18.3.2.1 Anabolic
- 18.3.3 Saudi Arabia Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 18.3.3.1 Protein
- 18.3.3.1.1 Saudi Arabia Protein Market Share and Revenue (USD Million) for 2018-2030
- 18.3.3.2 Beta-alanine
- 18.3.3.2.1 Saudi Arabia Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 18.3.3.3 Creatine
- 18.3.3.3.1 Saudi Arabia Creatine Market Share and Revenue (USD Million) for 2018-2030
- 18.3.3.4 Caffeine
- 18.3.3.4.1 Saudi Arabia Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 18.3.3.5 Others
- 18.3.3.5.1 Saudi Arabia Others Market Share and Revenue (USD Million) for 2018-2030
- 18.3.3.1 Protein
- 18.3.4 Saudi Arabia Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 18.3.4.1 Offline
- 18.3.4.1.1 Saudi Arabia Offline Market Share and Revenue (USD Million) for 2018-2030
- 18.3.4.2 Online
- 18.3.4.2.1 Saudi Arabia Online Market Share and Revenue (USD Million) for 2018-2030
- 18.3.4.1 Offline
- 18.3.1 Saudi Arabia Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.4 Turkey Androgens and Anabolic Steroids Market Size (2018-2030)
- 18.4.1 Turkey Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.4.1.1 Oral
- 18.4.1.1.1 Turkey Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.2 Injectables
- 18.4.1.2.1 Turkey Injectables Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.3 Topical
- 18.4.1.3.1 Turkey Topical Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.4 Others
- 18.4.1.4.1 Turkey Others Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.1 Oral
- 18.4.2 Turkey Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 18.4.2.1 Anabolic
- 18.4.2.1.1 Turkey Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 18.4.2.2 Androgenic
- 18.4.2.2.1 Turkey Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 18.4.2.3 Others
- 18.4.2.3.1 Turkey Others Market Share and Revenue (USD Million) for 2018-2030
- 18.4.2.1 Anabolic
- 18.4.3 Turkey Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 18.4.3.1 Protein
- 18.4.3.1.1 Turkey Protein Market Share and Revenue (USD Million) for 2018-2030
- 18.4.3.2 Beta-alanine
- 18.4.3.2.1 Turkey Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 18.4.3.3 Creatine
- 18.4.3.3.1 Turkey Creatine Market Share and Revenue (USD Million) for 2018-2030
- 18.4.3.4 Caffeine
- 18.4.3.4.1 Turkey Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 18.4.3.5 Others
- 18.4.3.5.1 Turkey Others Market Share and Revenue (USD Million) for 2018-2030
- 18.4.3.1 Protein
- 18.4.4 Turkey Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 18.4.4.1 Offline
- 18.4.4.1.1 Turkey Offline Market Share and Revenue (USD Million) for 2018-2030
- 18.4.4.2 Online
- 18.4.4.2.1 Turkey Online Market Share and Revenue (USD Million) for 2018-2030
- 18.4.4.1 Offline
- 18.4.1 Turkey Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.5 Nigeria Androgens and Anabolic Steroids Market Size (2018-2030)
- 18.5.1 Nigeria Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.5.1.1 Oral
- 18.5.1.1.1 Nigeria Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.2 Injectables
- 18.5.1.2.1 Nigeria Injectables Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.3 Topical
- 18.5.1.3.1 Nigeria Topical Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.4 Others
- 18.5.1.4.1 Nigeria Others Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.1 Oral
- 18.5.2 Nigeria Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 18.5.2.1 Anabolic
- 18.5.2.1.1 Nigeria Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 18.5.2.2 Androgenic
- 18.5.2.2.1 Nigeria Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 18.5.2.3 Others
- 18.5.2.3.1 Nigeria Others Market Share and Revenue (USD Million) for 2018-2030
- 18.5.2.1 Anabolic
- 18.5.3 Nigeria Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 18.5.3.1 Protein
- 18.5.3.1.1 Nigeria Protein Market Share and Revenue (USD Million) for 2018-2030
- 18.5.3.2 Beta-alanine
- 18.5.3.2.1 Nigeria Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 18.5.3.3 Creatine
- 18.5.3.3.1 Nigeria Creatine Market Share and Revenue (USD Million) for 2018-2030
- 18.5.3.4 Caffeine
- 18.5.3.4.1 Nigeria Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 18.5.3.5 Others
- 18.5.3.5.1 Nigeria Others Market Share and Revenue (USD Million) for 2018-2030
- 18.5.3.1 Protein
- 18.5.4 Nigeria Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 18.5.4.1 Offline
- 18.5.4.1.1 Nigeria Offline Market Share and Revenue (USD Million) for 2018-2030
- 18.5.4.2 Online
- 18.5.4.2.1 Nigeria Online Market Share and Revenue (USD Million) for 2018-2030
- 18.5.4.1 Offline
- 18.5.1 Nigeria Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.6 UAE Androgens and Anabolic Steroids Market Size (2018-2030)
- 18.6.1 UAE Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.6.1.1 Oral
- 18.6.1.1.1 UAE Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.2 Injectables
- 18.6.1.2.1 UAE Injectables Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.3 Topical
- 18.6.1.3.1 UAE Topical Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.4 Others
- 18.6.1.4.1 UAE Others Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.1 Oral
- 18.6.2 UAE Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 18.6.2.1 Anabolic
- 18.6.2.1.1 UAE Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 18.6.2.2 Androgenic
- 18.6.2.2.1 UAE Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 18.6.2.3 Others
- 18.6.2.3.1 UAE Others Market Share and Revenue (USD Million) for 2018-2030
- 18.6.2.1 Anabolic
- 18.6.3 UAE Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 18.6.3.1 Protein
- 18.6.3.1.1 UAE Protein Market Share and Revenue (USD Million) for 2018-2030
- 18.6.3.2 Beta-alanine
- 18.6.3.2.1 UAE Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 18.6.3.3 Creatine
- 18.6.3.3.1 UAE Creatine Market Share and Revenue (USD Million) for 2018-2030
- 18.6.3.4 Caffeine
- 18.6.3.4.1 UAE Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 18.6.3.5 Others
- 18.6.3.5.1 UAE Others Market Share and Revenue (USD Million) for 2018-2030
- 18.6.3.1 Protein
- 18.6.4 UAE Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 18.6.4.1 Offline
- 18.6.4.1.1 UAE Offline Market Share and Revenue (USD Million) for 2018-2030
- 18.6.4.2 Online
- 18.6.4.2.1 UAE Online Market Share and Revenue (USD Million) for 2018-2030
- 18.6.4.1 Offline
- 18.6.1 UAE Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.7 Egypt Androgens and Anabolic Steroids Market Size (2018-2030)
- 18.7.1 Egypt Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.7.1.1 Oral
- 18.7.1.1.1 Egypt Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.2 Injectables
- 18.7.1.2.1 Egypt Injectables Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.3 Topical
- 18.7.1.3.1 Egypt Topical Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.4 Others
- 18.7.1.4.1 Egypt Others Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.1 Oral
- 18.7.2 Egypt Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 18.7.2.1 Anabolic
- 18.7.2.1.1 Egypt Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 18.7.2.2 Androgenic
- 18.7.2.2.1 Egypt Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 18.7.2.3 Others
- 18.7.2.3.1 Egypt Others Market Share and Revenue (USD Million) for 2018-2030
- 18.7.2.1 Anabolic
- 18.7.3 Egypt Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 18.7.3.1 Protein
- 18.7.3.1.1 Egypt Protein Market Share and Revenue (USD Million) for 2018-2030
- 18.7.3.2 Beta-alanine
- 18.7.3.2.1 Egypt Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 18.7.3.3 Creatine
- 18.7.3.3.1 Egypt Creatine Market Share and Revenue (USD Million) for 2018-2030
- 18.7.3.4 Caffeine
- 18.7.3.4.1 Egypt Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 18.7.3.5 Others
- 18.7.3.5.1 Egypt Others Market Share and Revenue (USD Million) for 2018-2030
- 18.7.3.1 Protein
- 18.7.4 Egypt Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 18.7.4.1 Offline
- 18.7.4.1.1 Egypt Offline Market Share and Revenue (USD Million) for 2018-2030
- 18.7.4.2 Online
- 18.7.4.2.1 Egypt Online Market Share and Revenue (USD Million) for 2018-2030
- 18.7.4.1 Offline
- 18.7.1 Egypt Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.8 South Africa Androgens and Anabolic Steroids Market Size (2018-2030)
- 18.8.1 South Africa Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.8.1.1 Oral
- 18.8.1.1.1 South Africa Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.2 Injectables
- 18.8.1.2.1 South Africa Injectables Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.3 Topical
- 18.8.1.3.1 South Africa Topical Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.4 Others
- 18.8.1.4.1 South Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.1 Oral
- 18.8.2 South Africa Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 18.8.2.1 Anabolic
- 18.8.2.1.1 South Africa Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 18.8.2.2 Androgenic
- 18.8.2.2.1 South Africa Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 18.8.2.3 Others
- 18.8.2.3.1 South Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 18.8.2.1 Anabolic
- 18.8.3 South Africa Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 18.8.3.1 Protein
- 18.8.3.1.1 South Africa Protein Market Share and Revenue (USD Million) for 2018-2030
- 18.8.3.2 Beta-alanine
- 18.8.3.2.1 South Africa Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 18.8.3.3 Creatine
- 18.8.3.3.1 South Africa Creatine Market Share and Revenue (USD Million) for 2018-2030
- 18.8.3.4 Caffeine
- 18.8.3.4.1 South Africa Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 18.8.3.5 Others
- 18.8.3.5.1 South Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 18.8.3.1 Protein
- 18.8.4 South Africa Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 18.8.4.1 Offline
- 18.8.4.1.1 South Africa Offline Market Share and Revenue (USD Million) for 2018-2030
- 18.8.4.2 Online
- 18.8.4.2.1 South Africa Online Market Share and Revenue (USD Million) for 2018-2030
- 18.8.4.1 Offline
- 18.8.1 South Africa Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.9 GCC Countries Androgens and Anabolic Steroids Market Size (2018-2030)
- 18.9.1 GCC Countries Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.9.1.1 Oral
- 18.9.1.1.1 GCC Countries Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.9.1.2 Injectables
- 18.9.1.2.1 GCC Countries Injectables Market Share and Revenue (USD Million) for 2018-2030
- 18.9.1.3 Topical
- 18.9.1.3.1 GCC Countries Topical Market Share and Revenue (USD Million) for 2018-2030
- 18.9.1.4 Others
- 18.9.1.4.1 GCC Countries Others Market Share and Revenue (USD Million) for 2018-2030
- 18.9.1.1 Oral
- 18.9.2 GCC Countries Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 18.9.2.1 Anabolic
- 18.9.2.1.1 GCC Countries Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 18.9.2.2 Androgenic
- 18.9.2.2.1 GCC Countries Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 18.9.2.3 Others
- 18.9.2.3.1 GCC Countries Others Market Share and Revenue (USD Million) for 2018-2030
- 18.9.2.1 Anabolic
- 18.9.3 GCC Countries Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 18.9.3.1 Protein
- 18.9.3.1.1 GCC Countries Protein Market Share and Revenue (USD Million) for 2018-2030
- 18.9.3.2 Beta-alanine
- 18.9.3.2.1 GCC Countries Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 18.9.3.3 Creatine
- 18.9.3.3.1 GCC Countries Creatine Market Share and Revenue (USD Million) for 2018-2030
- 18.9.3.4 Caffeine
- 18.9.3.4.1 GCC Countries Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 18.9.3.5 Others
- 18.9.3.5.1 GCC Countries Others Market Share and Revenue (USD Million) for 2018-2030
- 18.9.3.1 Protein
- 18.9.4 GCC Countries Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 18.9.4.1 Offline
- 18.9.4.1.1 GCC Countries Offline Market Share and Revenue (USD Million) for 2018-2030
- 18.9.4.2 Online
- 18.9.4.2.1 GCC Countries Online Market Share and Revenue (USD Million) for 2018-2030
- 18.9.4.1 Offline
- 18.9.1 GCC Countries Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.10 Rest of MEA Androgens and Anabolic Steroids Market Size (2018-2030)
- 18.10.1 Rest of MEA Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 18.10.1.1 Oral
- 18.10.1.1.1 Rest of MEA Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.10.1.2 Injectables
- 18.10.1.2.1 Rest of MEA Injectables Market Share and Revenue (USD Million) for 2018-2030
- 18.10.1.3 Topical
- 18.10.1.3.1 Rest of MEA Topical Market Share and Revenue (USD Million) for 2018-2030
- 18.10.1.4 Others
- 18.10.1.4.1 Rest of MEA Others Market Share and Revenue (USD Million) for 2018-2030
- 18.10.1.1 Oral
- 18.10.2 Rest of MEA Androgens and Anabolic Steroids Market (USD Million) by Application (2018-2030)
- 18.10.2.1 Anabolic
- 18.10.2.1.1 Rest of MEA Anabolic Market Share and Revenue (USD Million) for 2018-2030
- 18.10.2.2 Androgenic
- 18.10.2.2.1 Rest of MEA Androgenic Market Share and Revenue (USD Million) for 2018-2030
- 18.10.2.3 Others
- 18.10.2.3.1 Rest of MEA Others Market Share and Revenue (USD Million) for 2018-2030
- 18.10.2.1 Anabolic
- 18.10.3 Rest of MEA Androgens and Anabolic Steroids Market (USD Million) by Ingredients (2018-2030)
- 18.10.3.1 Protein
- 18.10.3.1.1 Rest of MEA Protein Market Share and Revenue (USD Million) for 2018-2030
- 18.10.3.2 Beta-alanine
- 18.10.3.2.1 Rest of MEA Beta-alanine Market Share and Revenue (USD Million) for 2018-2030
- 18.10.3.3 Creatine
- 18.10.3.3.1 Rest of MEA Creatine Market Share and Revenue (USD Million) for 2018-2030
- 18.10.3.4 Caffeine
- 18.10.3.4.1 Rest of MEA Caffeine Market Share and Revenue (USD Million) for 2018-2030
- 18.10.3.5 Others
- 18.10.3.5.1 Rest of MEA Others Market Share and Revenue (USD Million) for 2018-2030
- 18.10.3.1 Protein
- 18.10.4 Rest of MEA Androgens and Anabolic Steroids Market (USD Million) by Distribution Channel (2018-2030)
- 18.10.4.1 Offline
- 18.10.4.1.1 Rest of MEA Offline Market Share and Revenue (USD Million) for 2018-2030
- 18.10.4.2 Online
- 18.10.4.2.1 Rest of MEA Online Market Share and Revenue (USD Million) for 2018-2030
- 18.10.4.1 Offline
- 18.10.1 Rest of MEA Androgens and Anabolic Steroids Market (USD Million) by Modes of Administration (2018-2030)
- 19.1 Key Takeaways
- 19.2 Analyst Point of View
Segmentation Level Customization | |
Global level Data Customization | |
Region level Data Customization | |
Country level Data Customization | |
Company Level | |
Additional Data Analysis | |
Additional Qualitative Data | |
Additional Quantitative Data | |
Service Level Customization | Report Format Alteration |
We have various report editions of Androgens and Anabolic Steroids Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Androgens and Anabolic Steroids Market Analysis
Global Androgens and Anabolic Steroids Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Androgens and Anabolic Steroids Industry growth. Androgens and Anabolic Steroids market has been segmented with the help of its Modes of Administration, Application Ingredients, and others. Androgens and Anabolic Steroids market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Report scope is customizable as we have a huge database of Androgens and Anabolic Steroids industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Major Modes of Administration Analysed |
|
Major Application Analysed |
|
Major Ingredients Analysed |
|
Major Distribution Channel Analysed |
|
Top Manufacturers Disclosed | |
Global, Regional and Country Analysis |
|
Key Qualitative Information Covered |
|
Oral segment has highest share owing to its convenience, and cost effectiveness. Moreover, it is widely preferred by patient due to its non-invasiveness nature and is highly patient-compliance.
However, injectables mode of administration also held significant share of 25.69% in the androgens and anabolic steroids market owing to its higher bioavailability. It is estimated that injectables will grow at a highest CAGR during the forecast period.
Androgens and Anabolic Steroids Market Share (%) by Modes of Administration in 2018-2030
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Androgens and Anabolic Steroids Industry. Request a Free Sample PDF!
Anabolic application accounts for highest share in the market which is attributed to its high use in the treatment of hormonal problems, delayed puberty, and muscle loss. It is also used as a mainstay of therapy for hypoplastic anaemias due to leukemia, kidney failure or aplastic anaemia.
Androgenic application held a market share of 33.25% and other applications held it at 24.39%.
Androgens and Anabolic Steroids Market Share (%) by Application in 2018-2030
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Androgens and Anabolic Steroids market report 2023 Edition by contacting our team.
Androgens and Anabolic Steroids Ingredients Segment Analysis
- Protein
- Beta-alanine
- Creatine
- Caffeine
- Others
Androgens and Anabolic Steroids Distribution Channel Segment Analysis
Online distribution of androgens and anabolic steroids is projected to grow at highest CAGR in coming years. An online distribution channel is the chain of a distribution network that uses online media. As manufacturers and distributors are presently inclined toward online sales, sale from online platforms is bound to increase. Further, increased use of smart phones and high penetration of social media enhances demand of androgens and anabolic steroids market. The revenue market share held by online androgens and anabolic steroids market was 31.05% in year 2022.
- Offline
- Online
High revenue in the North America region is primarily attributed to high prevalence of hypogonadism and other hormonal problems among population. Besides, presence of highly advanced and well-equipped healthcare infrastructure coupled with favourable healthcare policies are responsible for market dominance in the North America region.
Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Androgens and Anabolic Steroids Market Share (%) by Region (2018-2030)
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
Recent Developments:
April 2019
- Teva Pharmaceuticals has launched a generic version of testosterone gel:
Testosterone Gel 1.62% CIII has been indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. It has been also observed that Testosterone Gel 1.62% CIII had annual sales of around $911 million in the U.S. in the same year after its launch.
Top Companies Market Share in Androgens and Anabolic Steroids Industry: (In no particular order of Rank)
- F. Hoffmann-La Roche Ltd.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Sanofi
- GSK
- Novartis AG
- AstraZeneca
- Johnson & Johnson Private Limited
- Dr. Reddy’s Laboratories Ltd.
- Lupin
- Cipla Inc.
- Eli Lilly
- AbbVie Inc.
- Others
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..
Author's Conclusion
- Oral mode of administration segment has accounted for largest revenue share in of 41.04% in year 2022.
- Anabolic application held major market share of 42.36% in Androgens and Anabolic Steroids market.
- North America Androgens and Anabolic Steroids Market dominates overall market with a market share of 36.14%.
- Europe and APAC region also held significant share of 29.84% and 26.21% respectively.
Author's Detail
Surabhi Bhaiyya, LinkedIn
Senior Research Analyst at Cognitive Market Research
Surabhi Bhaiyya is an experienced market researcher focused on the Pharma & Healthcare industry. With over 7+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry. To get in touch and access the above report book an apointment at https://calendly.com/speak-to-analyst.
Key Questions Answered By Androgens and Anabolic Steroids Market Report 2023
Why Oral have a significant impact on Androgens and Anabolic Steroids market? |
What are the key factors affecting the Oral and Injectables of Androgens and Anabolic Steroids Market? |
What is the CAGR/Growth Rate of Anabolic during the forecast period? |
By type, which segment accounted for largest share of the global Androgens and Anabolic Steroids Market? |
Which region is expected to dominate the global Androgens and Anabolic Steroids Market within the forecast period? |
Frequently Asked Questions (FAQs)
Steep growth in the prevalence of hypogonadism is the primary factor responsible for the growth of androgens and anabolic steroids market
North America is dominating the Androgens and Anabolic Steroids market in year 2022.
Study involved in-depth qualitative and quantitative analyses of the market. Moreover, research study involves the use of secondary sources and databases such as key companies’ annual reports, paid & public database, Bloomberg, and Factiva to identify and collect information useful for a technical and market-oriented study of the global Androgens and Anabolic Steroids market. Market value evaluation is done by using top-down as well as bottom-up analysis.
Yes, the report includes a COVID-19 impact analysis.
Related Reports
- Measures to Explore Untapped Market
- Understanding Market Dynamics
- Understanding Changing Economics
- Competitors Market Share
- Global/Region/Country Level Analysis
- Identify Upcoming End Use Industries
- Global Price Trend Analysis
- Value Chain Analysis
- Customer Sentiment/Need Analysis
- Identification of Key Growth Segments
- Industry Upstream and Downstream Analysis
- Raw Material Sourcing and Cost Analysis
- Identify Key Customers Across Globe
- Concept Development and Market Testing
- Merger-Acquisition Strategy
- The research study and report are been made exclusively for an institution or person who is strategizing to build a business or strategically wants to expand certain portfolio.
- This report will help in analyzing complete market scenario across the globe who wish to expand their current business or is willing to invest in some profitable sector.
- This report will prove beneficial for person or an organization who wish to be updated regarding their business environment, consumers’ behaviour, and their requirements. The environment is constantly changing, and in such scenario, this report will help in understanding market parameters through 360-degree view.
- The report is thus ideal for KOL, CEO's, CFO's, directors, and others. It is also helpful to senior executives, business development managers, marketing managers, and consultants. Furthermore, government bodies, agencies and other kind of organizations can also leverage our report to understand market.
- Our objective for the Androgens and Anabolic Steroids market is to help in making imperative business decisions, securing investments, determining new business opportunities in the market. Further, the report helps to analyze overall marketing needs of customers, and avoid business failures.
- To know the potential market size and growth rate before launching a new product line. The report in a way helps in designing R&D budget wisely by estimating maximum total profit.
- To identify the Androgens and Anabolic Steroids market dynamics, industrial insights, and economic progression for critical information about the market conditions and specific business landscape.
- To assess the overall competitive landscape of a particular business sector and to provide complete analysis in regards with various external factors impacting the market growth.
- To create a strong foundation for building a strategy and foster insight into market conditions so that market players can make better business decisions. Besides, we aim to provide a complete portfolio of the major players involved the market.
- To define the scope which will further help in creating new products that will surpass the gap between current offerings and customers’ needs.
- To help in revealing significant clues concerning buying habits, regional culture, lifestyle, and population density that plays an integral role in shaping market behavior.
- To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the total market.
- Competitors Analysis: We provide data from the supplier side covering key details such as market share split among 1st tier, 2nd tier, and 3rd tier, Emerging Players, and Start-Ups. (whereas most of our competitors published data for top-tier companies)
- We provide market revenue share not only for Public listed companies but also the privately listed companies.
- Country Analysis: The Country level market split analysis is part of the report hence the data granularity is provided.
- We have been closely working with the Top 500 Fortune businesses, our clientele spanning 20+ industries. Our clientele is a mix of investors, manufacturers, end-users, distributors, etc. With our data subscription model (Athenaeum) 70% of clients have already subscribed/purchased reports for multiple years which helped us achieve unbelievable client retention statistics.
- Product + Service: In terms of the product we deliver the report access (PDF+ PPT+ EXCEL+ Cloud+ POWER BI) whereas in terms of service; we provide data support where a dedicated research analyst will be assigned and add-on benefits. (Whereas most of our competitors believe only in delivering the data/report and service and support remain questionable.)
- Credibility and Data Accuracy: We deliver accuracy close to 90-95% with the help of our in-house research team, freelancer, and industry expert network, sources present worldwide. This Data is backed up by strong What are our clients saying about our services.
Read more